Blessing or curse? Proteomics in granzyme research

Proteomics - Clinical Applications

Volumn 8, Issue 5-6, 2014, Pages 351-381

  Joeckel, Lars T ^a   Bird, Phillip I ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Granzyme; Serine proteases; Substrate specificity

Indexed keywords

CYTOKINE; GRANZYME; GRANZYME A; GRANZYME B; GRANZYME H; GRANZYME K; GRANZYME M; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROCASPASE 7; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; APOPTOSIS; ATHEROSCLEROSIS; BLOOD CLOTTING; CARDIOVASCULAR DISEASE; CELL DEATH; CYTOPLASM; CYTOTOXIC LYMPHOCYTE; DIABETES MELLITUS; ENZYME SPECIFICITY; HUMAN; INFLAMMATION; INNATE IMMUNITY; NEOPLASM; PNEUMONIA; PRIORITY JOURNAL; PROTEOMICS; REVIEW; SEPSIS; SPECIES DIFFERENCE; TARGET CELL; ANIMAL; DISEASES; METABOLISM; PROCEDURES;

ANIMALS; DISEASE; GRANZYMES; HUMANS; PROTEOMICS;

EID: 84902014396     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201300096     Document Type: Review

References (444)

1. Masson, D., Nabholz, M., Estrade, C., Tschopp, J., Granules of cytolytic T-lymphocytes contain two serine esterases. EMBO J. 1986, 5, 1595-1600.
2. Masson, D., Tschopp, J., A family of serine esterases in lytic granules of cytolytic T lymphocytes. Cell 1987, 49, 679-685.
3. Cullen, S. P., Brunet, M., Martin, S. J., Granzymes in cancer and immunity. Cell Death Differ. 2010, 17, 616-623.
4. Boivin, W. A., Cooper, D. M., Hiebert, P. R., Granville, D. J., Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma. Lab. Invest. 2009, 89, 1195-1220.
5. Joeckel, L. T., Bird, P. I., Are all granzymes cytotoxic in vivo? Biol. Chem. 2014, 395, 181-202.
6. Trapani, J. A., Sutton, V. R., Granzyme B: pro-apoptotic, antiviral and antitumor functions. Curr. Opin. Immunol. 2003, 15, 533-543.
7. Chowdhury, D., Lieberman, J., Death by a thousand cuts: granzyme pathways of programmed cell death. Annu. Rev. Immunol. 2008, 26, 389-420.
8. Metkar, S. S., Menaa, C., Pardo, J., Wang, B. et al., Human and mouse granzyme A induce a proinflammatory cytokine response. Immunity 2008, 29, 720-733.
9. Pardo, J., Aguilo, J. I., Anel, A., Martin, P. et al., The biology of cytotoxic cell granule exocytosis pathway: granzymes have evolved to induce cell death and inflammation. Microbes Infect. 2009, 11, 452-459.
10. Buzza, M. S., Bird, P. I., Extracellular granzymes: current perspectives. Biol. Chem. 2006, 387, 827-837.
11. Andrade, F., Non-cytotoxic antiviral activities of granzymes in the context of the immune antiviral state. Immunol. Rev. 2010, 235, 128-146.
12. Froelich, C. J., Pardo, J., Simon, M. M., Granule-associated serine proteases: granzymes might not just be killer proteases. Trends Immunol. 2009, 30, 117-123.
13. Grossman, W. J., Revell, P. A., Lu, Z. H., Johnson, H. et al., The orphan granzymes of humans and mice. Curr. Opin. Immunol. 2003, 15, 544-552.
14. Bredemeyer, A. J., Lewis, R. M., Malone, J. P., Davis, A. E. et al., A proteomic approach for the discovery of protease substrates. Proc. Natl. Acad. Sci. USA 2004, 101, 11785-11790.
15. Van Damme, P., Maurer-Stroh, S., Plasman, K., Van Durme, J. et al., Analysis of protein processing by N-terminal proteomics reveals novel species-specific substrate determinants of granzyme B orthologs. Mol. Cell Proteomics 2009, 8, 258-272.
16. Van Damme, P., Staes, A., Bronsoms, S., Helsens, K. et al., Complementary positional proteomics for screening substrates of endo- and exoproteases. Nat. Methods 2010, 7, 512-515.
17. Plasman, K., Van Damme, P., Kaiserman, D., Impens, F. et al., Probing the efficiency of proteolytic events by positional proteomics. Mol. Cell. Proteomics 2011, 10, M110.003301.
18. Bird, C. H., Sun, J., Ung, K., Karambalis, D. et al., Cationic sites on granzyme B contribute to cytotoxicity by promoting its uptake into target cells. Mol. Cell. Biol. 2005, 25, 7854-7867.
19. Kurschus, F. C., Fellows, E., Stegmann, E., Jenne, D. E., Granzyme B delivery via perforin is restricted by size, but not by heparan sulfate-dependent endocytosis. Proc. Natl. Acad. Sci. USA 2008, 105, 13799-13804.
20. Williams, M. S., Henkart, P. A., Apoptotic cell death induced by intracellular proteolysis. J. Immunol. 1994, 153, 4247-4255.
21. Martinvalet, D., Dykxhoorn, D. M., Ferrini, R., Lieberman, J., Granzyme A cleaves a mitochondrial complex I protein to initiate caspase-independent cell death. Cell 2008, 133, 681-692.
22. Rajani, D. K., Walch, M., Martinvalet, D., Thomas, M. P., Lieberman, J., Alterations in RNA processing during immune-mediated programmed cell death. Proc. Natl. Acad. Sci. USA 2012, 109, 8688-8693.
23. Bovenschen, N., Quadir, R., van den Berg, A. L., Brenkman, A. B. et al., Granzyme K displays highly restricted substrate specificity that only partially overlaps with granzyme A. J. Biol. Chem. 2009, 284, 3504-3512.
24. de Poot, S. A. H., Westgeest, M., Hostetter, D. R., Van Damme, P. et al., Human and mouse granzyme M display divergent and species-specific substrate specificities. Biochem. J. 2011, 437, 431-442.
25. auf dem Keller, U., Schilling, O., Proteomic techniques and activity-based probes for the system-wide study of proteolysis. Biochimie 2010, 92, 1705-1714.
26. Gevaert, K., Goethals, M., Martens, L., Van Damme, J. et al., Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides. Nat. Biotechnol. 2003, 21, 566-569.
27. Demon, D., Van Damme, P., Vanden Berghe, T., Deceuninck, A. et al., Proteome-wide substrate analysis indicates substrate exclusion as a mechanism to generate caspase-7 versus caspase-3 specificity. Mol. Cell. Proteomics 2009, 8, 2700-2714.
28. Vande Walle, L., Van Damme, P., Lamkanfi, M., Saelens, X. et al., Proteome-wide identification of HtrA2/Omi substrates. J. Proteome Res. 2007, 6, 1006-1015.
29. Krenacs, L., Smyth, M. J., Bagdi, E., Krenacs, T. et al., The serine protease granzyme M is preferentially expressed in NK-cell, gamma delta T-cell, and intestinal T-cell lymphomas: evidence of origin from lymphocytes involved in innate immunity. Blood 2003, 101, 3590-3593.
30. Van Damme, P., Martens, L., Van Damme, J., Hugelier, K. et al., Caspase-specific and nonspecific in vivo protein processing during Fas-induced apoptosis. Nat. Methods 2005, 2, 771-777.
31. Vögtle, F.-N., Wortelkamp, S., Zahedi, R. P., Becker, D. et al., Global analysis of the mitochondrial N-proteome identifies a processing peptidase critical for protein stability. Cell 2009, 139, 428-439.
32. Plasman, K., Maurer-Stroh, S., Ahmad, J., Hao, H. et al., Conservation of the extended substrate specificity profiles among homologous granzymes across species. Mol. Cell. Proteomics 2013, 12, 2921-2934.
33. Impens, F., Colaert, N., Helsens, K., Plasman, K. et al., MS-driven protease substrate degradomics. Proteomics 2010, 10, 1284-1296.
34. Simon, G. M., Dix, M. M., Cravatt, B. F., Comparative assessment of large-scale proteomic studies of apoptotic proteolysis. ACS Chem. Biol. 2009, 4, 401-408.
35. Kaiserman, D., Bird, C. H., Sun, J., Matthews, A. et al., The major human and mouse granzymes are structurally and functionally divergent. J. Cell. Biol. 2006, 175, 619-630.
36. Adrain, C., Murphy, B. M., Martin, S. J., Molecular ordering of the caspase activation cascade initiated by the cytotoxic T lymphocyte/natural killer (CTL/NK) protease granzyme B. J. Biol. Chem. 2005, 280, 4663-4673.
37. Andrade, F., Roy, S., Nicholson, D., Thornberry, N. et al., Granzyme B directly and efficiently cleaves several downstream caspase substrates: implications for CTL-induced apoptosis. Immunity 1998, 8, 451-460.
38. Chipuk, J. E., Medema, J. P., Medema, J. P., Moldoveanu, T. et al., Cleavage of FLICE (caspase-8) by granzyme B during cytotoxic T lymphocyte-induced apoptosis. Eur. J. Immunol. 1997, 27, 3492-3498.
39. Martin, S. J., Amarante-Mendes, G. P., Shi, L., Chuang, T. H. et al., The cytotoxic cell protease granzyme B initiates apoptosis in a cell-free system by proteolytic processing and activation of the ICE/CED-3 family protease, CPP32, via a novel two-step mechanism. EMBO J. 1996, 15, 2407-2416.
40. Van de Craen, M., Van den Brande, I., Declercq, W., Irmler, M. et al., Cleavage of caspase family members by granzyme B: a comparative study in vitro. Eur. J. Immunol. 1997, 27, 1296-1299.
41. Buzza, M. S., Zamurs, L., Sun, J., Bird, C. H. et al., Extracellular matrix remodeling by human granzyme B via cleavage of vitronectin, fibronectin, and laminin. J. Biol. Chem. 2005, 280, 23549-23558.
42. Afonina, I. S., Tynan, G. A., Logue, S. E., Cullen, S. P. et al., Granzyme B-dependent proteolysis acts as a switch to enhance the proinflammatory activity of IL-1α. Mol. Cell 2011, 44, 265-278.
43. Buzza, M. S., Dyson, J. M., Choi, H., Gardiner, E. E. et al., Antihemostatic activity of human granzyme B mediated by cleavage of von Willebrand factor. J. Biol. Chem. 2008, 283, 22498-22504.
44. Knickelbein, J. E., Khanna, K. M., Yee, M. B., Baty, C. J. et al., Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency. Science 2008, 322, 268-271.
45. de Graaf, E. L., Altelaar, A. F. M., van Breukelen, B., Mohammed, S., Heck, A. J. R., Improving SRM assay development: a global comparison between triple quadrupole, ion trap, and higher energy CID peptide fragmentation spectra. J. Proteome Res. 2011, 10, 4334-4341.
46. Rousalova, I., Krepela, E., Granzyme B-induced apoptosis in cancer cells and its regulation (review). Int. J. Oncol. 2010, 37, 1361-1378.
47. Scott, G. B., Bowles, P. A., Wilson, E. B., Meade, J. L. et al., Identification of the BCL2/adenovirus E1B-19K protein-interacting protein 2 (BNIP-2) as a granzyme B target during human natural killer cell-mediated killing. Biochem. J. 2010, 431, 423-431.
48. Cullen, S. P., Adrain, C., Lüthi, A. U., Duriez, P. J., Martin, S. J., Human and murine granzyme B exhibit divergent substrate preferences. J. Cell. Biol. 2007, 176, 435-444.
49. Masson, D., Zamai, M., Tschopp, J., Identification of granzyme A isolated from cytotoxic T-lymphocyte-granules as one of the proteases encoded by CTL-specific genes. FEBS Lett. 1986, 208, 84-88.
50. Simon, M. M., Hoschützky, H., Fruth, U., Simon, H. G., Kramer, M. D., Purification and characterization of a T cell specific serine proteinase (TSP-1) from cloned cytolytic T lymphocytes. EMBO J 1986, 5, 3267-3274.
51. Hink-Schauer, C., Estébanez-Perpiñá, E., Kurschus, F. C., Bode, W., Jenne, D. E., Crystal structure of the apoptosis-inducing human granzyme A dimer. Nat. Struct. Biol. 2003, 10, 535-540.
52. Bell, J. K., Goetz, D. H., Mahrus, S., Harris, J. L. et al., The oligomeric structure of human granzyme A is a determinant of its extended substrate specificity. Nat. Struct. Biol. 2003, 10, 527-534.
53. Simon, M. M., Kramer, M. D., Granzyme A. Meth. Enzymol. 1994, 244, 68-79.
54. Lieberman, J., Granzyme A activates another way to die. Immunol. Rev. 2010, 235, 93-104.
55. Simon, M. M., Simon, H. G., Fruth, U., Epplen, J. et al., Cloned cytolytic T-effector cells and their malignant variants produce an extracellular matrix degrading trypsin-like serine proteinase. Immunology 1987, 60, 219-230.
56. Hirayasu, H., Yoshikawa, Y., Tsuzuki, S., Fushiki, T., A lymphocyte serine protease granzyme A causes detachment of a small-intestinal epithelial cell line (IEC-6). Biosci. Biotechnol. Biochem. 2008, 72, 2294-2302.
57. Simon, M. M., Kramer, M. D., Prester, M., Gay, S., Mouse T-cell associated serine proteinase 1 degrades collagen type IV: a structural basis for the migration of lymphocytes through vascular basement membranes. Immunology 1991, 73, 117-119.
58. Simon, H. G., Fruth, U., Kramer, M. D., Simon, M. M., A secretable serine proteinase with highly restricted specificity from cytolytic T lymphocytes inactivates retrovirus-associated reverse transcriptase. FEBS Lett. 1987, 223, 352-360.
59. Tsubota, K., Saito, I., Miyasaka, N., Expression of granzyme A and perforin in lacrimal gland of Sjögren's syndrome. Adv. Exp. Med. Biol. 1994, 350, 637-640.
60. Held, W., MacDonald, H. R., Weissman, I. L., Hess, M. W., Mueller, C., Genes encoding tumor necrosis factor alpha and granzyme A are expressed during development of autoimmune diabetes. Proc. Natl. Acad. Sci. USA 1990, 87, 2239-2243.
61. Bade, B., Lohrmann, J., Brinke ten, A., Wolbink, A. M. et al., Detection of soluble human granzyme K in vitro and in vivo. Eur. J. Immunol. 2005, 35, 2940-2948.
62. Smith, K. J., Hamza, S., Skelton, H., Topical imidazoquinoline therapy of cutaneous squamous cell carcinoma polarizes lymphoid and monocyte/macrophage populations to a Th1 and M1 cytokine pattern. Clin. Exp. Dermatol. 2004, 29, 505-512.
63. Téo, F. H., de Oliveira, R. T. D., Mamoni, R. L., Ferreira, M. C. S. et al., Characterization of CD4+CD28null T cells in patients with coronary artery disease and individuals with risk factors for atherosclerosis. Cell. Immunol. 2013, 281, 11-19.
64. Muris, J. J. F., Ylstra, B., Cillessen, S. A. G. M., Ossenkoppele, G. J. et al., Profiling of apoptosis genes allows for clinical stratification of primary nodal diffuse large B-cell lymphomas. Br. J. Haematol. 2007, 136, 38-47.
65. Banerjea, A., Ahmed, S., Hands, R. E., Huang, F. et al., Colorectal cancers with microsatellite instability display mRNA expression signatures characteristic of increased immunogenicity. Mol. Cancer 2004, 3, 21.
66. Soghoian, D. Z., Jessen, H., Flanders, M., Sierra-Davidson, K. et al., HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome. Sci. Transl. Med. 2012, 4, 123ra25.
67. Napoli, A. M., Fast, L. D., Gardiner, F., Nevola, M., Machan, J. T., Increased granzyme levels in cytotoxic T lymphocytes are associated with disease severity in emergency department patients with severe sepsis. Shock 2012, 37, 257-262.
68. Van Damme, P., Maurer-Stroh, S., Hao, H., Colaert, N. et al., The substrate specificity profile of human granzyme A. Biol. Chem. 2010, 391, 983-997.
69. Edwards, K. M., Kam, C. M., Powers, J. C., Trapani, J. A., The human cytotoxic T cell granule serine protease granzyme H has chymotrypsin-like (chymase) activity and is taken up into cytoplasmic vesicles reminiscent of granzyme B-containing endosomes. J. Biochem. 1999, 274, 30468-30473.
70. Mahrus, S., Craik, C. S., Selective chemical functional probes of granzymes A and B reveal granzyme B is a major effector of natural killer cell-mediated lysis of target cells. Chem. Biol. 2005, 12, 567-577.
71. Fellows, E., Gil-Parrado, S., Jenne, D. E., Kurschus, F. C., Natural killer cell-derived human granzyme H induces an alternative, caspase-independent cell-death program. Blood 2007, 110, 544-552.
72. Hou, Q., Zhao, T., Zhang, H., Lu, H. et al., Granzyme H induces apoptosis of target tumor cells characterized by DNA fragmentation and Bid-dependent mitochondrial damage. Mol. Immunol. 2008, 45, 1044-1055.
73. Ewen, C. L., Kane, K. P., Bleackley, R. C., Granzyme H induces cell death primarily via a Bcl-2-sensitive mitochondrial cell death pathway that does not require direct Bid activation. Mol. Immunol. 2013, 54, 309-318.
74. Andrade, F., Fellows, E., Jenne, D. E., Rosen, A., Young, C. S. H., Granzyme H destroys the function of critical adenoviral proteins required for viral DNA replication and granzyme B inhibition. EMBO J. 2007, 26, 2148-2157.
75. Tang, H., Li, C., Wang, L., Zhang, H., Fan, Z., Granzyme H of cytotoxic lymphocytes is required for clearance of the hepatitis B virus through cleavage of the hepatitis B virus X protein. J. Immunol. 2012, 188, 4629-4638.
76. Sedelies, K. A., Discordant regulation of granzyme H and granzyme B expression in human lymphocytes. J. Biol. Chem. 2004, 279, 26581-26587.
77. Razvi, N. Z., Khurshid, R., Nagra, S. A., To study the significance of apoptotic enzyme granzyme H in breast cancer patients. J. Ayub. Med. Coll. Abbottabad 2008, 20, 84-86.
78. Kelly, J. M., O'Connor, M. D., Hulett, M. D., Thia, K. Y., Smyth, M. J., Cloning and expression of the recombinant mouse natural killer cell granzyme Met-ase-1. Immunogenetics 1996, 44, 340-350.
79. Smyth, M. J., Sayers, T. J., Wiltrout, T., Powers, J. C., Trapani, J. A., Met-ase: cloning and distinct chromosomal location of a serine protease preferentially expressed in human natural killer cells. J. Immunol. 1993, 151, 6195-6205.
80. Kelly, J. M., Waterhouse, N. J., Cretney, E., Browne, K. A. et al., Granzyme M mediates a novel form of perforin-dependent cell death. J. Biochem. 2004, 279, 22236-22242.
81. Lu, H., Hou, Q., Zhao, T., Zhang, H. et al., Granzyme M directly cleaves inhibitor of caspase-activated DNase (CAD) to unleash CAD leading to DNA fragmentation. J. Immunol. 2006, 177, 1171-1178.
82. Cullen, S. P., Afonina, I. S., Donadini, R., Lüthi, A. U. et al., Nucleophosmin is cleaved and inactivated by the cytotoxic granule protease granzyme M during natural killer cell-mediated killing. J. Biochem. 2009, 284, 5137-5147.
83. Hollestelle, M. J., Lai, K. W., van Deuren, M., Lenting, P. J. et al., Cleavage of von Willebrand factor by granzyme M destroys its factor VIII binding capacity. PLoS ONE 2011, 6, e24216.
84. Anthony, D. A., Andrews, D. M., Chow, M., Watt, S. V. et al., A role for granzyme M in TLR4-driven inflammation and endotoxicosis. J. Immunol. 2010, 185, 1794-1803.
85. van Domselaar, R., de Poot, S. A. H., Remmerswaal, E. B. M., Lai, K. W. et al., Granzyme M targets host cell hnRNP K that is essential for human cytomegalovirus replication. Cell Death Differ. 2013, 20, 419-429.
86. Mahrus, S., Kisiel, W., Craik, C. S., Granzyme M is a regulatory protease that inactivates proteinase inhibitor 9, an endogenous inhibitor of granzyme B. J. Biol. Chem. 2004, 279, 54275-54282.
87. de Poot, S. A. H., Lai, K. W., van der Wal, L., Plasman, K. et al., Granzyme M targets topoisomerase II alpha to trigger cell cycle arrest and caspase-dependent apoptosis. Cell Death Differ. 2014, 21, 416-426.
88. Zhao, T., Zhang, H., Guo, Y., Zhang, Q. et al., Granzyme K cleaves the nucleosome assembly protein SET to induce single-stranded DNA nicks of target cells. Cell Death Differ. 2007, 14, 489-499.
89. Zhao, T., Zhang, H., Guo, Y., Fan, Z., Granzyme K directly processes bid to release cytochrome c and endonuclease G leading to mitochondria-dependent cell death. J. Biol. Chem. 2007, 282, 12104-12111.
90. Guo, Y., Chen, J., Zhao, T., Fan, Z., Granzyme K degrades the redox/DNA repair enzyme Ape1 to trigger oxidative stress of target cells leading to cytotoxicity. Mol. Immunol. 2008, 45, 2225-2235.
91. Hua, G., Wang, S., Zhong, C., Xue, P., Fan, Z., Ignition of p53 bomb sensitizes tumor cells to granzyme K-mediated cytolysis. J. Immunol. 2009, 182, 2152-2159.
92. Guo, Y., Chen, J., Shi, L., Fan, Z., Valosin-containing protein cleavage by granzyme K accelerates an endoplasmic reticulum stress leading to caspase-independent cytotoxicity of target tumor cells. J. Immunol. 2010, 185, 5348-5359.
93. Joeckel, L. T., Wallich, R., Martin, P., Sanchez-Martinez, D. et al., Mouse granzyme K has pro-inflammatory potential. Cell Death Differ. 2011, 18, 1112-1119.
94. Cooper, D. M., Pechkovsky, D. V., Hackett, T. L., Granville, D. J., Granzyme K activates protease-activated receptor-1. PLoS ONE 2011, 6, e21484.
95. Zhong, C., Li, C., Wang, X., Toyoda, T. et al., Granzyme K inhibits replication of influenza virus through cleaving the nuclear transport complex importin α1/β dimer of infected host cells. Cell Death Differ. 2012, 19, 882-890.
96. Al-Lamki, Z., Wali, Y. A., Wasifuddin, S. M., Zachariah, M. et al., Identification of prognosis markers in pediatric high-risk acute lymphoblastic leukemia. Pediatr. Hematol. Oncol. 2005, 22, 629-643.
97. Rucevic, M., Fast, L. D., Jay, G. D., Trespalcios, F. M. et al., Altered levels and molecular forms of granzyme k in plasma from septic patients. Shock 2007, 27, 488-493.
98. Lim, Y.-P., Bendelja, K., Opal, S. M., Siryaporn, E. et al., Correlation between mortality and the levels of inter-alpha inhibitors in the plasma of patients with severe sepsis. J. Infect. Dis. 2003, 188, 919-926.
99. Singh, K., Zhang, L. X., Bendelja, K., Heath, R. et al., Inter-alpha inhibitor protein administration improves survival from neonatal sepsis in mice. Pediatr. Res. 2010, 68, 242-247.
100. Bratke, K., Klug, A., Julius, P., Kuepper, M. et al., Granzyme K: a novel mediator in acute airway inflammation. Thorax 2008, 63, 1006-1011.
101. Bürckstümmer, T., Banning, C., Hainzl, P., Schobesberger, R. et al., A reversible gene trap collection empowers haploid genetics in human cells. Nat. Methods 2013, 10, 965-971.
102. Grossman, W. J., Radhi, M., Schauer, D., Gerday, E. et al., Development of hemophagocytic lymphohistiocytosis in triplets infected with HHV-8. Blood 2005, 106, 1203-1206.
103. Cherin, P., Herson, S., Crevon, M. C., Hauw, J. J. et al., Mechanisms of lysis by activated cytotoxic cells expressing perforin and granzyme-B genes and the protein TIA-1 in muscle biopsies of myositis. J. Rheumatol. 1996, 23, 1135-1142.
104. Orimo, S., Koga, R., Goto, K., Nakamura, K. et al., Immunohistochemical analysis of perforin and granzyme A in inflammatory myopathies. Neuromuscul. Disord. 1994, 4, 219-226.
105. Nield, L. E., Silverman, E. D., Smallhorn, J. F., Taylor, G. P. et al., Endocardial fibroelastosis associated with maternal anti-Ro and anti-La antibodies in the absence of atrioventricular block. J. Am. Coll. Cardiol. 2002, 40, 796-802.
106. Schachna, L., Wigley, F. M., Morris, S., Gelber, A. C. et al., Recognition of granzyme B-generated autoantigen fragments in scleroderma patients with ischemic digital loss. Arthritis Rheum. 2002, 46, 1873-1884.
107. Mulligan-Kehoe, M. J., Drinane, M. C., Mollmark, J., Casciola-Rosen, L. et al., Antiangiogenic plasma activity in patients with systemic sclerosis. Arthritis Rheum. 2007, 56, 3448-3458.
108. Tabbara, K., Sharara, N., Sjögren's syndrome: pathogenesis. Eur. J. Ophthalmol. 1999, 9, 1-7.
109. Polihronis, M., Tapinos, N. I., Theocharis, S. E., Economou, A. et al., Modes of epithelial cell death and repair in Sjögren's syndrome (SS). Clin. Exp. Immunol. 1998, 114, 485-490.
110. Huang, M., Ida, H., Kamachi, M., Iwanaga, N. et al., Detection of apoptosis-specific autoantibodies directed against granzyme B-induced cleavage fragments of the SS-B (La) autoantigen in sera from patients with primary Sjögren's syndrome. Clin. Exp. Immunol. 2005, 142, 148-154.
111. Blanco, P., Pitard, V., Viallard, J.-F., Taupin, J.-L. et al., Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum. 2005, 52, 201-211.
112. Graham, K. L., Utz, P. J., Sources of autoantigens in systemic lupus erythematosus. Curr. Opin. Rheumatol. 2005, 17, 513-517.
113. Thomas, H. E., Trapani, J. A., Kay, T. W. H., The role of perforin and granzymes in diabetes. Cell Death Differ. 2010, 17, 577-585.
114. Estella, E., McKenzie, M. D., Catterall, T., Sutton, V. R. et al., Granzyme B-mediated death of pancreatic beta-cells requires the proapoptotic BH3-only molecule bid. Diabetes 2006, 55, 2212-2219.
115. Chen, J., Zajac, A. J., McPherson, S. A., Hsu, H.-C. et al., Primary adenovirus-specific cytotoxic T lymphocyte response occurs after viral clearance and liver enzyme elevation. Gene Ther. 2005, 12, 1079-1088.
116. Manigold, T., Martinez, J., Lazcano, X., Ye, C. et al., Case report: T-cell responses during clearance of Andes virus from blood cells 2 months after severe hantavirus cardiopulmonary syndrome. J. Med. Virol. 2008, 80, 1947-1951.
117. Dadhania, D., Snopkowski, C., Ding, R., Muthukumar, T. et al., Validation of noninvasive diagnosis of BK virus nephropathy and identification of prognostic biomarkers. Transplantation 2010, 90, 189-197.
118. Kamalakaran, S., Chaganty, B. K. R., Gupta, R., Guentzel, M. N. et al., Vaginal chlamydial clearance following primary or secondary infection in mice occurs independently of TNF-α. Front Cell. Infect Microbiol 2013, 3, 11.
119. Rentenaar, R. J., Wever, P. C., van Diepen, F. N., Out, T. A. et al., Concomitant detection by flow cytometry of the intragranular antigen granzyme B and the intranuclear antigen Ki-67 in peripheral blood mononuclear cells from healthy individuals and patients with acute CMV infection after renal transplantation. Transplant. Proc. 1998, 30, 3958-3959.
120. Berge, ten, I. J., Wever, P. C., Wolbink, A. M., Surachno, J. et al., Increased systemic levels of soluble granzymes A and B during primary cytomegalovirus infection after renal transplantation. Transplant. Proc. 1998, 30, 3972-3974.
121. van Domselaar, R., Philippen, L. E., Quadir, R., Wiertz, E. J. H. J. et al., Noncytotoxic inhibition of cytomegalovirus replication through NK cell protease granzyme M-mediated cleavage of viral phosphoprotein 71. J. Immunol. 2010, 185, 7605-7613.
122. Casazza, J. P., Betts, M. R., Price, D. A., Precopio, M. L. et al., Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation. J. Exp. Med. 2006, 203, 2865-2877.
123. van Leeuwen, E. M. M., Remmerswaal, E. B. M., Vossen, M. T. M., Rowshani, A. T. et al., Emergence of a CD4+CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection. J. Immunol. 2004, 173, 1834-1841.
124. Müllbacher, A., Ebnet, K., Blanden, R. V., Hla, R. T. et al., Granzyme A is critical for recovery of mice from infection with the natural cytopathic viral pathogen, ectromelia. Proc. Natl. Acad. Sci. USA 1996, 93, 5783-5787.
125. Pardo, J., Gálvez, E. M., Koskinen, A., Simon, M. M. et al., Caspase-dependent inhibition of mousepox replication by gzmB. PLoS ONE 2009, 4, e7512.
126. Shimizu, M., Higaki, Y., Higaki, M., Kawashima, M., The role of granzyme B-expressing CD8-positive T cells in apoptosis of keratinocytes in lichen planus. Arch. Dermatol. Res. 1997, 289, 527-532.
127. Stevenson, H. L., Estes, M. D., Thirumalapura, N. R., Walker, D. H., Ismail, N., Natural killer cells promote tissue injury and systemic inflammatory responses during fatal Ehrlichia-induced toxic shock-like syndrome. Am. J. Pathol. 2010, 177, 766-776.
128. Lee, W.-I., Lin, J.-J., Hsieh, M.-Y., Lin, S.-J. et al., Immunologic difference between hypersensitivity to mosquito bite and hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus infection. PLoS ONE 2013, 8, e76711.
129. Spaeny-Dekking, E. H., Hanna, W. L., Wolbink, A. M., Wever, P. C. et al., Extracellular granzymes A and B in humans: detection of native species during CTL responses in vitro and in vivo. J. Immunol. 1998, 160, 3610-3616.
130. Sanapala, S., Yu, J.-J., Murthy, A. K., Li, W. et al., Perforin- and granzyme-mediated cytotoxic effector functions are essential for protection against Francisella tularensis following vaccination by the defined F. tularensis subsp. novicida ΔfopC vaccine strain. Infect. Immun. 2012, 80, 2177-2185.
131. + T cells during low-level Friend retrovirus infection. Retrovirology 2013, 10, 109.
132. Kraft, A. R. M., Krux, F., Schimmer, S., Ohlen, C. et al., CpG oligodeoxynucleotides allow for effective adoptive T-cell therapy in chronic retroviral infection. Blood 2007, 109, 2982-2984.
133. Zelinskyy, G., Balkow, S., Schimmer, S., Schepers, K. et al., Independent roles of perforin, granzymes, and Fas in the control of Friend retrovirus infection. Virology 2004, 330, 365-374.
134. Zelinskyy, G., Robertson, S. J., Schimmer, S., Messer, R. J. et al., CD8+ T-cell dysfunction due to cytolytic granule deficiency in persistent Friend retrovirus infection. J. Virol. 2005, 79, 10619-10626.
135. Yawalkar, N., Schmid, S., Braathen, L. R., Pichler, W. J., Perforin and granzyme B may contribute to skin inflammation in atopic dermatitis and psoriasis. Br. J. Dermatol. 2001, 144, 1133-1139.
136. Gupta, S., Braun, M., Tischler, N. D., Stoltz, M. et al., Hantavirus-infection confers resistance to cytotoxic lymphocyte-mediated apoptosis. PLoS Pathog. 2013, 9, e1003272.
137. 64-72 from hepatitis B virus core protein. Int. Immunopharmacol. 2012, 13, 141-147.
138. Tang, T. J., Kwekkeboom, J., Mancham, S., Binda, R. S. et al., Intrahepatic CD8 +T-lymphocyte response is important for therapy-induced viral clearance in chronic hepatitis B infection. J. Hepatol. 2005, 43, 45-52.
139. Schwartz, R. A., McDonough, P. H., Lee, B. W., Toxic epidermal necrolysis: part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis. J. Am. Acad. Dermatol. 2013, 69, 173.e1-13.
140. Antonaci, S., Schiraldi, O., Costimulatory molecules and cytotoxic T cells in chronic hepatitis C: defence mechanisms devoted to host integrity or harmful events favouring liver injury progression? A review. 1998, 20, 455-472.
141. + T cell responses. Infect. Immun. 2013, 81, 3803-3813.
142. + intraepithelial lymphocytes contributes to epithelial apoptosis in Helicobacter pylori-associated lymphocytic gastritis. Helicobacter 2013, 81, 290-298.
143. Lin, J.-S., Yang, C.-W., Wang, D.-W., Wu-Hsieh, B. A., Dendritic cells cross-present exogenous fungal antigens to stimulate a protective CD8 T cell response in infection by Histoplasma capsulatum. J. Immunol. 2005, 174, 6282-6291.
144. Jiang, Y., Zhou, F., Tian, Y., Zhang, Z. et al., Higher NK cell IFN-γ production is associated with delayed HIV disease progression in LTNPs. J. Clin. Immunol. 2013, 33, 1376-1385.
145. Snijders, F., Wever, P. C., Danner, S. A., Hack, C. E. et al., Increased numbers of granzyme-B-expressing cytotoxic T-lymphocytes in the small intestine of HIV-infected patients. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1996, 12, 276-281.
146. Koopman, G., Wever, P. C., Ramkema, M. D., Bellot, F. et al., Expression of granzyme B by cytotoxic T lymphocytes in the lymph nodes of HIV-infected patients. AIDS Res. Hum. Retroviruses 1997, 13, 227-233.
147. Shacklett, B. L., Cox, C. A., Quigley, M. F., Kreis, C. et al., Abundant expression of granzyme A, but not perforin, in granules of CD8+ T cells in GALT: implications for immune control of HIV-1 infection. J. Immunol. 2004, 173, 641-648.
148. Andersson, J., Behbahani, H., Lieberman, J., Connick, E. et al., Perforin is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infection. AIDS 1999, 13, 1295-1303.
149. Trimble, L. A., Lieberman, J., Circulating CD8 T lymphocytes in human immunodeficiency virus-infected individuals have impaired function and downmodulate CD3 zeta, the signaling chain of the T-cell receptor complex. Blood 1998, 91, 585-594.
150. Espersen, C., Pakkenberg, B., Harder, E., Pallesen, G. et al., High levels of CD8-positive lymphocytes expressing CD45R0, granzyme B, and Ki-67 in lymph nodes of HIV-infected individuals are not associated with increased mortality. AIDS Res. Hum. Retroviruses 2001, 17, 287-293.
151. Held, K., Derfuss, T., Control of HSV-1 latency in human trigeminal ganglia-current overview. J. Neurovirol. 2011, 17, 518-527.
152. Khanna, K. M., Lepisto, A. J., Hendricks, R. L., Immunity to latent viral infection: many skirmishes but few fatalities. Trends Immunol. 2004, 25, 230-234.
153. Oliveira, A. L. A., Hayakawa, H., Schor, D., Leite, A. C. C. B. et al., High frequencies of functionally competent circulating Tax-specific CD8+ T cells in human T lymphotropic virus type 2 infection. J. Immunol. 2009, 183, 2957-2965.
154. Wang, X., Rosa, A. J. M., Oliverira, H. N., Rosa, G. J. M. et al., Transcriptome of local innate and adaptive immunity during early phase of infectious bronchitis viral infection. Viral Immunol. 2006, 19, 768-774.
155. Jenkins, M. R., Trapani, J. A., Doherty, P. C., Turner, S. J., Granzyme K expressing cytotoxic T lymphocytes protects against influenza virus in granzyme AB/mice. Viral Immunol. 2008, 21, 341-346.
156. Moffat, J. M., Gebhardt, T., Doherty, P. C., Turner, S. J., Mintern, J. D., Granzyme A expression reveals distinct cytolytic CTL subsets following influenza A virus infection. Eur. J. Immunol. 2009, 39, 1203-1210.
157. + T cells with cytotoxic potential during influenza virus infection. J. Virol. 2013, 87, 11884-11893.
158. Brown, D. M., Lee, S., Garcia-Hernandez, M., de, L. L., Swain, S. L., Multifunctional CD4 cells expressing gamma interferon and perforin mediate protection against lethal influenza virus infection. J. Virol. 2012, 86, 6792-6803.
159. Brown, D. M., Lee, S., Garcia-Hernandez, M., de L. L., Swain, S. L., Multifunctional CD4 cells expressing gamma interferon and perforin mediate protection against lethal influenza virus infection. J. Virol. 2012, 86, 6792-6803.
160. Johnson, B. J., Costelloe, E. O., Fitzpatrick, D. R., Haanen, J. B. A. G. et al., Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice. Proc. Natl. Acad. Sci. USA 2003, 100, 2657-2662.
161. Frischholz, S., Röllinghoff, M., Moll, H., Cutaneous leishmaniasis: co-ordinate expression of granzyme A and lymphokines by CD4+ T cells from susceptible mice. Immunology 1994, 82, 255-260.
162. Eisert, V., Münster, U., Simon, M. M., Moll, H., The course of Leishmania major infection in mice lacking granzyme-mediated mechanisms. Immunobiology 2002, 205, 314-320.
163. Faria, D. R., Souza, P. E. A., Durães, F. V., Carvalho, E. M. et al., Recruitment of CD8(+) T cells expressing granzyme A is associated with lesion progression in human cutaneous leishmaniasis. Parasite Immunol. 2009, 31, 432-439.
164. Faria, D. R., Gollob, K. J., Barbosa, J., Schriefer, A. et al., Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis. Infect. Immun. 2005, 73, 7853-7859.
165. De Fost, M., Chierakul, W., Limpaiboon, R., Dondorp, A. et al., Release of granzymes and chemokines in Thai patients with leptospirosis. Clin. Microbiol. Infect. 2007, 13, 433-436.
166. Carrero, J. A., Vivanco-Cid, H., Unanue, E. R., Granzymes drive a rapid listeriolysin O-induced T cell apoptosis. J. Immunol. 2008, 181, 1365-1374.
167. Hartmann, W., Marsland, B. J., Otto, B., Urny, J. et al., A novel and divergent role of granzyme A and B in resistance to helminth infection. J. Immunol. 2011, 186, 2472-2481.
168. Müller, C., Kägi, D., Aebischer, T., Odermatt, B. et al., Detection of perforin and granzyme A mRNA in infiltrating cells during infection of mice with lymphocytic choriomeningitis virus. Eur. J. Immunol. 1989, 19, 1253-1259.
169. Sarson, A. J., Abdul-Careem, M. F., Zhou, H., Sharif, S., Transcriptional analysis of host responses to Marek's disease viral infection. Viral Immunol. 2006, 19, 747-758.
170. Vuorinen, T., Peri, P., Vainionpää, R., Measles virus induces apoptosis in uninfected bystander T cells and leads to granzyme B and caspase activation in peripheral blood mononuclear cell cultures. Eur. J. Clin. Invest. 2003, 33, 434-442.
171. Hollestelle, M. J., Sprong, T., Bovenschen, N., de Mast, Q. et al., von Willebrand factor activation, granzyme-B and thrombocytopenia in meningococcal disease. J. Thromb. Haemost. 2010, 8, 1098-1106.
172. Riera, L., Gariglio, M., Valente, G., Müllbacher, A. et al., Murine cytomegalovirus replication in salivary glands is controlled by both perforin and granzymes during acute infection. Eur. J. Immunol. 2000, 30, 1350-1355.
173. Wang, Y., Lobigs, M., Lee, E., Müllbacher, A., Exocytosis and Fas mediated cytolytic mechanisms exert protection from West Nile virus induced encephalitis in mice. Immunol. Cell Biol. 2004, 82, 170-173.
174. Casciola-Rosen, L., Miagkov, A., Nagaraju, K., Askin, F. et al., Granzyme B: evidence for a role in the origin of myasthenia gravis. J. Neuroimmunol. 2008, 201-202, 33-40.
175. Toossi, Z., Mayanja-Kizza, H., Kanost, A., Edmonds, K. et al., Protective responses in tuberculosis: induction of genes for interferon-gamma and cytotoxicity by Mycobacterium tuberculosis and during human tuberculosis. Scand. J. Immunol. 2004, 60, 299-306.
176. Heuss, D., Probst-Cousin, S., Kayser, C., Neundörfer, B., Cell death in vasculitic neuropathy. Muscle Nerve 2000, 23, 999-1004.
177. Fujiwara, A., Kawai, Y., Sekikawa, S., Horii, T. et al., Villus epithelial injury induced by infection with the nematode Nippostrongylus brasiliensis is associated with upregulation of granzyme B. J. Parasitol. 2004, 90, 1019-1026.
178. Burlandy-Soares, L. C., Mamoni, R. L., Lyra, L., Schreiber, A. Z., Blotta, M. H. S. L., Expression of activation and cytotoxic molecules by peripheral blood lymphocytes of patients with paracoccidioidomycosis. Med. Mycol. 2010, 48, 843-852.
179. Lau, L. S., Fernández Ruiz, D., Davey, G. M., de Koning-Ward, T. F. et al., Blood-stage Plasmodium berghei infection generates a potent, specific CD8+ T-cell response despite residence largely in cells lacking MHC I processing machinery. J. Infect. Dis. 2011, 204, 1989-1996.
180. Haque, A., Best, S. E., Unosson, K., Amante, F. H. et al., Granzyme B expression by CD8+ T cells is required for the development of experimental cerebral malaria. J. Immunol. 2011, 186, 6148-6156.
181. Miyakoda, M., Kimura, D., Yuda, M., Chinzei, Y. et al., Malaria-specific and nonspecific activation of CD8+ T cells during blood stage of Plasmodium berghei infection. J. Immunol. 2008, 181, 1420-1428.
182. Hoji, A., Rinaldo, C. R., Human CD8+ T cells specific for influenza A virus M1 display broad expression of maturation-associated phenotypic markers and chemokine receptors. Immunology 2005, 115, 239-245.
183. Hu, W.-C., Human immune responses to Plasmodium falciparum infection: molecular evidence for a suboptimal THalphabeta and TH17 bias over ideal and effective traditional TH1 immune response. Malar. J. 2013, 12, 392.
184. Troye-Blomberg, M., Worku, S., Tangteerawatana, P., Jamshaid, R. et al., Human gamma delta T cells that inhibit the in vitro growth of the asexual blood stages of the Plasmodium falciparum parasite express cytolytic and proinflammatory molecules. Scand. J. Immunol. 1999, 50, 642-650.
185. Korbel, D. S., Newman, K. C., Almeida, C. R., Davis, D. M., Riley, E. M., Heterogeneous human NK cell responses to Plasmodium falciparum-infected erythrocytes. J. Immunol. 2005, 175, 7466-7473.
186. Sandri, M., Meslemani El, A. H., Sandri, C., Schjerling, P. et al., Caspase 3 expression correlates with skeletal muscle apoptosis in Duchenne and facioscapulo human muscular dystrophy. A potential target for pharmacological treatment? J. Neuropathol. Exp. Neurol. 2001, 60, 302-312.
187. Chandele, A., Mukerjee, P., Das, G., Ahmed, R., Chauhan, V. S., Phenotypic and functional profiling of malaria-induced CD8 and CD4 T cells during blood-stage infection with Plasmodium yoelii. Immunology 2011, 132, 273-286.
188. Ohshima, K., Shimazaki, K., Kume, T., Suzumiya, J. et al., Perforin and Fas pathways of cytotoxic T-cells in histiocytic necrotizing lymphadenitis. Histopathology 1998, 33, 471-478.
189. Kelly, M. N., Zheng, M., Ruan, S., Kolls, J. et al., Memory CD4+ T cells are required for optimal NK cell effector functions against the opportunistic fungal pathogen Pneumocystis murina. J. Immunol. 2013, 190, 285-295.
190. Toquet, C., Hamidou, M. A., Renaudin, K., Jarry, A. et al., In situ immunophenotype of the inflammatory infiltrate in eosinophilic fasciitis. J. Rheumatol. 2003, 30, 1811-1815.
191. Klingström, J., Hardestam, J., Stoltz, M., Zuber, B. et al., Loss of cell membrane integrity in puumala hantavirus-infected patients correlates with levels of epithelial cell apoptosis and perforin. J. Virol. 2006, 80, 8279-8282.
192. Loebbermann, J., Thornton, H., Durant, L., Sparwasser, T. et al., Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infection. Mucosal Immunol. 2012, 5, 161-172.
193. Lee, S.-J., Dunmire, S., McSorley, S. J., MHC class-I-restricted CD8 T cells play a protective role during primary Salmonella infection. Immunol. Lett. 2012, 148, 138-143.
194. Chen, H., Hou, J., Jiang, X., Ma, S. et al., Response of memory CD8+ T cells to severe acute respiratory syndrome (SARS) coronavirus in recovered SARS patients and healthy individuals. J. Immunol. 2005, 175, 591-598.
195. Zheng, X. X., Steele, A. W., Nickerson, P. W., Steurer, W. et al., Administration of noncytolytic IL-10/Fc in murine models of lipopolysaccharide-induced septic shock and allogeneic islet transplantation. J. Immunol. 2005, 154, 5590-5600.
196. Raqib, R., Ekberg, C., Sharkar, P., Bardhan, P. K. et al., Apoptosis in acute shigellosis is associated with increased production of Fas/Fas ligand, perforin, caspase-1, and caspase-3 but reduced production of Bcl-2 and interleukin-2. Infect. Immun. 2002, 70, 3199-3207.
197. Marcondes, M. C., Burudi, E. M., Huitron-Resendiz, S., Sanchez-Alavez, M. et al., Highly activated CD8(+) T cells in the brain correlate with early central nervous system dysfunction in simian immunodeficiency virus infection. J. Immunol. 2001, 167, 5429-5438.
198. van Voorhis, W. C., Barrett, L. K., Nasio, J. M., Plummer, F. A., Lukehart, S. A., Lesions of primary and secondary syphilis contain activated cytolytic T cells. Infect. Immun. 1996, 64, 1048-1050.
199. Egui, A., Thomas, M. C., Morell, M., Marañón, C. et al., Trypanosoma cruzi paraflagellar rod proteins 2 and 3 contain immunodominant CD8(+) T-cell epitopes that are recognized by cytotoxic T cells from Chagas disease patients. Mol. Immunol. 2012, 52, 289-298.
200. + cytotoxic lymphocytes and apoptosis markers induced by Trypanossoma cruzi infection. Scand. J. Immunol. 2012, 76, 311-319.
201. Teixeira, P. C., Iwai, L. K., Kuramoto, A. C. K., Honorato, R. et al., Proteomic inventory of myocardial proteins from patients with chronic Chagas' cardiomyopathy. Braz. J. Med. Biol. Res. 2006, 39, 1549-1562.
202. Müller, U., Sobek, V., Balkow, S., Hölscher, C. et al., Concerted action of perforin and granzymes is critical for the elimination of Trypanosoma cruzi from mouse tissues, but prevention of early host death is in addition dependent on the FasL/Fas pathway. Eur. J. Immunol. 2003, 33, 70-78.
203. Kumar, S., Tarleton, R. L., The relative contribution of antibody production and CD8+ T cell function to immune control of Trypanosoma cruzi. Parasite Immunol. 1998, 20, 207-216.
204. Rock, M. T., Yoder, S. M., Wright, P. F., Talbot, T. R. et al., Differential regulation of granzyme and perforin in effector and memory T cells following smallpox immunization. J. Immunol. 2005, 174, 3757-3764.
205. Ali, R., Naqvi, R. A., Kumar, S., Bhat, A. A., Rao, D. N., Multiple antigen peptide containing B and T cell epitopes of F1 antigen of Yersinia pestis showed enhanced Th1 immune response in murine model. Scand. J. Immunol. 2013, 77, 361-371.
206. Classen, C. F., Ushmorov, A., Bird, P., Debatin, K.-M., The granzyme B inhibitor PI-9 is differentially expressed in all main subtypes of pediatric acute lymphoblastic leukemias. Haematologica 2004, 89, 1314-1321.
207. Scheibenbogen, C., Letsch, A., Thiel, E., Schmittel, A. et al., CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia. Blood 2002, 100, 2132-2137.
208. Shimauchi, T., Hirokawa, Y., Tokura, Y., Purpuric adult T-cell leukaemia/lymphoma: expansion of unusual CD4/CD8 double-negative malignant T cells expressing CCR4 but bearing the cytotoxic molecule granzyme B. Br. J. Dermatol. 2005, 152, 350-352.
209. Kozako, T., Arima, N., Toji, S., Masamoto, I. et al., Reduced frequency, diversity, and function of human T cell leukemia virus type 1-specific CD8+ T cell in adult T cell leukemia patients. J. Immunol. 2006, 177, 5718-5726.
210. Mori, N., Yamashita, Y., Tsuzuki, T., Nakayama, A. et al., Lymphomatous features of aggressive NK cell leukaemia/lymphoma with massive necrosis, haemophagocytosis and EB virus infection. Histopathology 2000, 37, 363-371.
211. Foss, H. D., Anagnostopoulos, I., Araujo, I., Assaf, C. et al., Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules. Blood 1996, 88, 4005-4011.
212. Foss, H. D., Demel, G., Anagnostopoulos, I., Araujo, I. et al., Uniform expression of cytotoxic molecules in anaplastic large cell lymphoma of null/T cell phenotype and in cell lines derived from anaplastic large cell lymphoma. Pathobiology 1997, 65, 83-90.
213. Jaffe, E. S., Krenacs, L., Raffeld, M., Classification of T-cell and NK-cell neoplasms based on the REAL classification. Ann. Oncol. 1997, 8(Suppl 2), 17-24.
214. Kummer, J. A., Vermeer, M. H., Dukers, D., Meijer, C. J., Willemze, R., Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype. J. Invest. Dermatol. 1997, 109, 636-640.
215. Ng, C. S., Lo, S. T., Chan, J. K., Chan, W. C., CD56+ putative natural killer cell lymphomas: production of cytolytic effectors and related proteins mediating tumor cell apoptosis? Hum. Pathol. 1997, 28, 1276-1282.
216. Dukers, D. F., Berge ten, R. L., Oudejans, J. J., Pulford, K. et al., A cytotoxic phenotype does not predict clinical outcome in anaplastic large cell lymphomas. J. Clin. Pathol. 1999, 52, 129-136.
217. Mori, N., Watanabe, K., Yamashita, Y., Nakayama, A. et al., Hodgkin disease with subsequent transformation to CD30 positive non-hodgkin lymphoma in six patients. Cancer 1999, 85, 970-979.
218. Berge ten, R. L., Dukers, D. F., Oudejans, J. J., Pulford, K. et al., Adverse effects of activated cytotoxic T lymphocytes on the clinical outcome of nodal anaplastic large cell lymphoma. Blood 1999, 93, 2688-2696.
219. Kagami, Y., Suzuki, R., Taji, H., Yatabe, Y. et al., Nodal cytotoxic lymphoma spectrum: a clinicopathologic study of 66 patients. Am. J. Surg. Pathol. 1999, 23, 1184-1200.
220. Nagasaka, T., Nakamura, S., Medeiros, L. J., Juco, J., Lai, R., Anaplastic large cell lymphomas presented as bone lesions: a clinicopathologic study of six cases and review of the literature. Mod. Pathol. 2000, 13, 1143-1149.
221. Chuang, S. S., Huang, W., Lin, C. N., Chio, C. C. et al., Primary cerebral anaplastic large cell lymphoma containing abundant reactive histiocytes and eosinophils. A case report and literature review. Pathol. Res. Pract. 2001, 197, 647-652.
222. Berge ten, R. L., Oudejans, J. J., Dukers, D. F., Meijer, J. W. et al., Percentage of activated cytotoxic T-lymphocytes in anaplastic large cell lymphoma and Hodgkin's disease: an independent biological prognostic marker. Leukemia 2001, 15, 458-464.
223. d'Amore, E. S. G., Menin, A., Bonoldi, E., Bevilacqua, P. et al., Anaplastic large cell lymphomas: a study of 75 pediatric patients. Pediatr. Dev. Pathol. 2007, 10, 181-191.
224. Richaud-Patin, Y., Piedras, J., Carrillo-Maravilla, E., López-Karpovitch, X., Llorente, L., CD8 +chronic lymphocytic leukemia: an extensive characterization of a bizarre hybrid neoplasia. Eur. J. Haematol. 2003, 71, 224-230.
225. Katrinakis, G., Kyriakou, D., Papadaki, H., Kalokyri, I. et al., Defective natural killer cell activity in B-cell chronic lymphocytic leukaemia is associated with impaired release of natural killer cytotoxic factor(s) but not of tumour necrosis factor-alpha. Acta Haematol. 1996, 96, 16-23.
226. Porakishvili, N., Kardava, L., Jewell, A. P., Yong, K. et al., Cytotoxic CD4+ T cells in patients with B cell chronic lymphocytic leukemia kill via a perforin-mediated pathway. Haematologica 2004, 89, 435-443.
227. Atanackovic, D., Panse, J., Schafhausen, P., Faltz, C. et al., Peripheral T cells of patients with B cell non-Hodgkin's lymphoma show a shift in their memory status. Leuk. Res. 2005, 29, 1019-1027.
228. Yang, Z.-Z., Novak, A. J., Ziesmer, S. C., Witzig, T. E., Ansell, S. M., Attenuation of CD8(+) T-cell function by CD4(+)CD25(+) regulatory T cells in B-cell non-Hodgkin's lymphoma. Cancer Res. 2006, 66, 10145-10152.
229. Martinez, A., Pittaluga, S., Villamor, N., Colomer, D. et al., Clonal T-cell populations and increased risk for cytotoxic T-cell lymphomas in B-CLL patients: clinicopathologic observations and molecular analysis. Am. J. Surg. Pathol. 2004, 28, 849-858.
230. Vermi, W., Facchetti, F., Rosati, S., Vergoni, F. et al., Nodal and extranodal tumor-forming accumulation of plasmacytoid monocytes/interferon-producing cells associated with myeloid disorders. Am. J. Surg. Pathol. 2004, 28, 585-595.
231. Petrella, T., Dalac, S., Maynadié, M., Mugneret, F. et al., CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Français d'Etude des Lymphomes Cutanés (GFELC). Am. J. Surg. Pathol. 1999, 23, 137-146.
232. Boulland, M. L., Wechsler, J., Bagot, M., Pulford, K. et al., Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins. Histopathology 2000, 36, 136-144.
233. Toro, J. R., Beaty, M., Sorbara, L., Turner, M. L. et al., gamma delta T-cell lymphoma of the skin: a clinical, microscopic, and molecular study. Arch. Dermatol. 2000, 136, 1024-1032.
234. Kamarashev, J., Burg, G., Mingari, M. C., Kempf, W. et al., Differential expression of cytotoxic molecules and killer cell inhibitory receptors in CD8+ and CD56 +cutaneous lymphomas. Am. J. Pathol. 2001, 158, 1593-1598.
235. Nevala, H., Karenko, L., Vakeva, L., Ranki, A., Proapoptotic and antiapoptotic markers in cutaneous T-cell lymphoma skin infiltrates and lymphomatoid papulosis. Br. J. Dermatol. 2001, 145, 928-937.
236. Vermeer, M. H., van Doorn, R., Dukers, D., Bekkenk, M. W. et al., CD8+ T cells in cutaneous T-cell lymphoma: expression of cytotoxic proteins, Fas Ligand, and killing inhibitory receptors and their relationship with clinical behavior. J. Clin. Oncol. 2001, 19, 4322-4329.
237. Lu, D., Patel, K. A., Duvic, M., Jones, D., Clinical and pathological spectrum of CD8-positive cutaneous T-cell lymphomas. J. Cutan. Pathol. 2002, 29, 465-472.
238. Takeshita, M., Yamamoto, M., Kikuchi, M., Kimura, N. et al., Angiodestruction and tissue necrosis of skin-involving CD56+ NK/T-cell lymphoma are influenced by expression of cell adhesion molecules and cytotoxic granule and apoptosis-related proteins. Am. J. Clin. Pathol. 2000, 113, 201-211.
239. Wenzel, J., Gütgemann, I., Distelmaier, M., Uerlich, M. et al., The role of cytotoxic skin-homing CD8+ lymphocytes in cutaneous cytotoxic T-cell lymphoma and pityriasis lichenoides. J. Am. Acad. Dermatol. 2005, 53, 422-427.
240. Muris, J. J. F., Meijer, C. J. L. M., Cillessen, S. A. G. M., Vos, W. et al., Prognostic significance of activated cytotoxic T-lymphocytes in primary nodal diffuse large B-cell lymphomas. Leukemia 2004, 18, 589-596.
241. Lee, A. M., Clear, A. J., Calaminici, M., Davies, A. J. et al., Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome. J. Clin. Oncol. 2006, 24, 5052-5059.
242. Mori, N., Murakami, Y. I., Shimada, S., Iwamizu-Watanabe, S. et al., TIA-1 expression in hairy cell leukemia. Mod. Pathol. 2004, 17, 840-846.
243. Takaku, T., Miyazawa, K., Sashida, G., Shoji, N. et al., Hepatosplenic alphabeta T-cell lymphoma with myelodysplastic syndrome. Int. J. Hematol. 2005, 82, 143-147.
244. Salhany, K. E., Feldman, M., Kahn, M. J., Peritt, D. et al., Hepatosplenic gammadelta T-cell lymphoma: ultrastructural, immunophenotypic, and functional evidence for cytotoxic T lymphocyte differentiation. Hum. Pathol. 1997, 28, 674-685.
245. Boulland, M. L., Kanavaros, P., Wechsler, J., Casiraghi, O., Gaulard, P., Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas. J. Pathol. 1997, 183, 432-439.
246. Ohshima, K., Haraoka, S., Harada, N., Kamimura, T. et al., Hepatosplenic gammadelta T-cell lymphoma: relation to Epstein-Barr virus and activated cytotoxic molecules. Histopathology 2000, 36, 127-135.
247. Sadahira, Y., Notohara, K., Manabe, T., Hepatosplenic T cell lymphoma with no expression of cytotoxic molecules. J. Clin. Pathol. 2003, 56, 631-633.
248. Belhadj, K., Reyes, F., Farcet, J.-P., Tilly, H. et al., Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood 2003, 102, 4261-4269.
249. Niitsu, N., Kohri, M., Togano, T., Nakamine, H. et al., Development of hepatosplenic gammadelta T-cell lymphoma with pancytopenia during early pregnancy: a case report and review of the literature. Eur. J. Haematol. 2004, 73, 367-371.
250. Oudejans, J. J., Kummer, J. A., Jiwa, M., van der Valk, P. et al., Granzyme B expression in Reed-Sternberg cells of Hodgkin's disease. Am. J. Pathol. 1996, 148, 233-240.
251. Oudejans, J. J., Jiwa, N. M., Kummer, J. A., Horstman, A. et al., Analysis of major histocompatibility complex class I expression on Reed-Sternberg cells in relation to the cytotoxic T-cell response in Epstein-Barr virus-positive and -negative Hodgkin's disease. Blood 1996, 87, 3844-3851.
252. Oudejans, J. J., Jiwa, N. M., Kummer, J. A., Ossenkoppele, G. J. et al., Activated cytotoxic T cells as prognostic marker in Hodgkin's disease. Blood 1997, 89, 1376-1382.
253. Dukers, D. F., Jaspars, L. H., Vos, W., Oudejans, J. J. et al., Quantitative immunohistochemical analysis of cytokine profiles in Epstein-Barr virus-positive and -negative cases of Hodgkin's disease. J. Pathol. 2000, 190, 143-149.
254. Axdorph, U., Porwit-MacDonald, A., Grimfors, G., Björkholm, M., Tissue eosinophilia in relation to immunopathological and clinical characteristics in Hodgkin's disease. Leuk. Lymphoma 2001, 42, 1055-1065.
255. Alvaro, T., Lejeune, M., Salvadó, M. T., Bosch, R. et al., Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells. Clin. Cancer Res. 2005, 11, 1467-1473.
256. Alvaro-Naranjo, T., Lejeune, M., Salvadó-Usach, M. T., Bosch-Príncep, R. et al., Tumor-infiltrating cells as a prognostic factor in Hodgkin's lymphoma: a quantitative tissue microarray study in a large retrospective cohort of 267 patients. Leuk. Lymphoma 2005, 46, 1581-1591.
257. Asano, N., Suzuki, R., Kagami, Y., Ishida, F. et al., Clinicopathologic and prognostic significance of cytotoxic molecule expression in nodal peripheral T-cell lymphoma, unspecified. Am. J. Surg. Pathol. 2005, 29, 1284-1293.
258. Daum, S., Foss, H. D., Anagnostopoulos, I., Dederke, B. et al., Expression of cytotoxic molecules in intestinal T-cell lymphomas. The German Study Group on Intestinal Non-Hodgkin Lymphoma. J. Pathol. 1997, 182, 311-317.
259. Chott, A., Vesely, M., Simonitsch, I., Mosberger, I., Hanak, H., Classification of intestinal T-cell neoplasms and their differential diagnosis. Am. J. Clin. Pathol. 1999, 111, S68-74.
260. Wu, H., Said, J. W., Ames, E. D., Chen, C. et al., First reported cases of intravascular large cell lymphoma of the NK cell type: clinical, histologic, immunophenotypic, and molecular features. Am. J. Clin. Pathol. 2005, 123, 603-611.
261. Takahashi, E., Kajimoto, K., Fukatsu, T., Yoshida, M. et al., Intravascular large T-cell lymphoma: a case report of CD30-positive and ALK-negative anaplastic type with cytotoxic molecule expression. Virchows Arch. 2005, 447, 1000-1006.
262. Ren, T., Yang, J., Broeg, K., Liu, X. et al., Developing an in vitro model of T cell type of large granular lymphocyte leukemia. Leuk. Res. 2013, 37, 1737-1743.
263. Kothapalli, R., Bailey, R. D., Kusmartseva, I., Mane, S. et al., Constitutive expression of cytotoxic proteases and down-regulation of protease inhibitors in LGL leukemia. Int. J. Oncol. 2003, 22, 33-39.
264. Bigouret, V., Hoffmann, T., Arlettaz, L., Villard, J. et al., Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C/E and NKD2D killer cell receptors. Blood 2003, 101, 3198-3204.
265. Morice, W. G., Jevremovic, D., Hanson, C. A., The expression of the novel cytotoxic protein granzyme M by large granular lymphocytic leukaemias of both T-cell and NK-cell lineage: an unexpected finding with implications regarding the pathobiology of these disorders. Br. J. Haematol. 2007, 137, 237-239.
266. Yamashita, Y., Nakamura, S., Kagami, Y., Hasegawa, Y. et al., Lennert's lymphoma: a variant of cytotoxic T-cell lymphoma? Am. J. Surg. Pathol. 2000, 24, 1627-1633.
267. Kojima, H., Shimizu, S., Yoshida, C., Katsura, Y. et al., Rapidly progressive Lennert's lymphoma terminating in fulminant hepatic failure. Leuk. Lymphoma 2003, 44, 1409-1412.
268. Kitamura, A., Yamashita, Y., Sato, Y., Hasegawa, Y. et al., Aggressive Lennert"s lymphoma: report of three cases in comparison to non-aggressive Lennert's lymphoma. Pathol. Int. 2005, 55, 626-631.
269. Michalopoulos, P., Yawalkar, N., Brönnimann, M., Kappeler, A., Braathen, L. R., Characterization of the cellular infiltrate during successful topical treatment of lentigo maligna with imiquimod. Br. J. Dermatol. 2004, 151, 903-906.
270. Rybojad, P., Jablonka, A., Wilczyńska, B., Tabarkiewicz, J., Surgery decreases number of cells secreting cytotoxic mediators and increases secretion of interleukin 10 in patients with lung cancer. Eur. J. Surg. Oncol. 2013, 39, 1269-1277.
271. Devergne, O., Raphael, M., Autran, B., Leger-Ravet, M. B. et al., Intratumoral activation of CD8-positive cytotoxic lymphocytes in acquired immunodeficiency syndrome lymphomas. Hum. Pathol. 1995, 26, 284-290.
272. Wu, W.-M., Tsai, H.-J., Lymphomatoid papulosis histopathologically simulating angiocentric and cytotoxic T-cell lymphoma: a case report. Am. J. Dermatopathol. 2004, 26, 133-135.
273. Magro, C. M., Crowson, A. N., Morrison, C., Merati, K. et al., CD8+ lymphomatoid papulosis and its differential diagnosis. Am. J. Clin. Pathol. 2006, 125, 490-501.
274. Flann, S., Orchard, G. E., Wain, E. M., Russell-Jones, R., Three cases of lymphomatoid papulosis with a CD56+ immunophenotype. J. Am. Acad. Dermatol. 2006, 55, 903-906.
275. Schroers, R., Hildebrandt, Y., Steffens, R., Becker, S. et al., Immunophenotypic and genetic characterization of a CD8 positive mantle cell lymphoma in a patient with concomitant Mycosis fungoides. Eur. J. Haematol. 2005, 75, 78-84.
276. Leger-Ravet, M. B., Mathiot, C., Portier, A., Brandely, M. et al., Increased expression of perforin and granzyme B genes in patients with metastatic melanoma treated with recombinant interleukin-2. Cancer Immunol. Immunother. 1994, 39, 53-58.
277. Yang, S., Haluska, F. G., Treatment of melanoma with 5-fluorouracil or dacarbazine in vitro sensitizes cells to antigen-specific CTL lysis through perforin/granzyme- and Fas-mediated pathways. J. Immunol. 2004, 172, 4599-4608.
278. Guillot, B., Portalès, P., Thanh, A. D., Merlet, S. et al., The expression of cytotoxic mediators is altered in mononuclear cells of patients with melanoma and increased by interferon-alpha treatment. Br. J. Dermatol. 2005, 152, 690-696.
279. Wenzel, J., Bekisch, B., Uerlich, M., Haller, O. et al., Type I interferon-associated recruitment of cytotoxic lymphocytes: a common mechanism in regressive melanocytic lesions. Am. J. Clin. Pathol. 2005, 124, 37-48.
280. Choi, S.-L., Choi, Y.-S., Kim, Y.-K., Sung, N.-D. et al., Proteomic analysis and the antimetastatic effect of N-(4-methyl)phenyl-O-(4-methoxy) phenyl-thionocarbamate-induced apoptosis in human melanoma SK-MEL-28 cells. Arch. Pharm. Res. 2006, 29, 224-234.
281. Xagoraris, I., Paterakis, G., Zolota, B., Zikos, P. et al., Expression of granzyme B and perforin in multiple myeloma. Acta. Haematol. 2001, 105, 125-129.
282. Zheng, C., Ostad, M., Andersson, M., Celsing, F. et al., Natural cytotoxicity to autologous antigen-pulsed dendritic cells in multiple myeloma. Br. J. Haematol. 2002, 118, 778-785.
283. de Haart, S. J., van de Donk, N. W. C. J., Minnema, M. C., Huang, J. H. et al., Accessory cells of the microenvironment protect multiple myeloma from T-cell cytotoxicity through cell adhesion-mediated immune resistance. Clin. Cancer Res. 2013, 19, 5591-5601.
284. Asadullah, K., Friedrich, M., Haeubetaler, A., Sterry, W. et al., Granzyme A mRNA expression in mycosis fungoides progression. Blood 1997, 90, 3810-3811.
285. Vermeer, M. H., Geelen, F. A., Kummer, J. A., Meijer, C. J., Willemze, R., Expression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage disease. Am. J. Pathol. 1999, 154, 1203-1210.
286. Ichimura, K., Kagami, Y., Suzuki, R., Kojima, M. et al., Phenotypic analysis of peripheral T/NK cell lymphoma: study of 408 Japanese cases with special reference to their anatomical sites. Pathol. Int. 2003, 53, 333-344.
287. Cho, M. S., Lee, M. K., Yang, W. I., Yoon, J. H., Granzyme B immunoreactivity in T/natural killer cell lymphomas. Yonsei Med. J. 1997, 38, 285-293.
288. Kagami, Y., Nakamura, S., Suzuki, R., Iida, S. et al., Establishment of an IL-2-dependent cell line derived from "nasal-type" NK/T-cell lymphoma of CD2+, sCD3-, CD3epsilon+, CD56+ phenotype and associated with the Epstein-Barr virus. Br. J. Haematol. 1998, 103, 669-677.
289. Yamashita, Y., Tsuzuki, T., Nakayama, A., Fujino, M., Mori, N., A case of natural killer/T cell lymphoma of the subcutis resembling subcutaneous panniculitis-like T cell lymphoma. Pathol. Int. 1999, 49, 241-246.
290. Sadahira, Y., Wada, H., Nakamura, E., Terayama, K. et al., Nasal NK/T cell lymphoma presenting as transverse myelopathy. Virchows Arch. 2000, 436, 393-397.
291. Kuwabara, H., Tsuji, M., Yoshii, Y., Kakuno, Y. et al., Nasal-type NK/T cell lymphoma of the orbit with distant metastases. Hum. Pathol. 2003, 34, 290-292.
292. García-Cosío, M., Santón, A., Méndez, M. C., Rivas, C. et al., Nasopharyngeal/nasal type T/NK lymphomas: analysis of 14 cases and review of the literature. Tumori 2003, 89, 278-284.
293. Ng, S. B., Lai, K. W., Murugaya, S., Lee, K. M. et al., Nasal-type extranodal natural killer/T-cell lymphomas: a clinicopathologic and genotypic study of 42 cases in Singapore. Mod. Pathol. 2004, 17, 1097-1107.
294. Kitamura, A., Yamashita, Y., Hasegawa, Y., Kojima, H. et al., Primary lymphoma arising in the nasal cavity among Japanese. Histopathology 2005, 47, 523-532.
295. Li, T., Zhang, B., Ye, Y., Yin, H., Immunohistochemical and genetic analysis of Chinese nasal natural killer/T-cell lymphomas. Hum. Pathol. 2006, 37, 54-60.
296. Kaluza, V., Rao, D. S., Said, J. W., de Vos, S., Primary extranodal nasal-type natural killer/T-cell lymphoma of the brain: a case report. Hum. Pathol. 2006, 37, 769-772.
297. Ko, Y.-H., Park, S., Jin, H., Woo, H. et al., Granzyme B leakage-induced apoptosis is a crucial mechanism of cell death in nasal-type NK/T-cell lymphoma. Lab. Invest. 2007, 87, 241-250.
298. Smyth, M. J., Wiltrout, T., Trapani, J. A., Ottaway, K. S. et al., Purification and cloning of a novel serine protease, RNK-Met-1, from the granules of a rat natural killer cell leukemia. J. Biol. Chem. 1992, 267, 24418-24425.
299. Drénou, B., Lamy, T., Amiot, L., Fardel, O. et al., CD3- CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance. Blood 1997, 89, 2966-2974.
300. Kim, G. E., Yang, W. I., Lee, S., Kim, Y. B. et al., The significance of granzyme B expression in patients with angiocentric lymphoma of the head and neck. Cancer 2001, 91, 2343-2352.
301. Dargent, J. L., Roufosse, C., Vanderschueren, B., Nouwynck, C. et al., Natural killer-like T-cell lymphoma of the stomach. Scand. J. Gastroenterol. 1999, 34, 445-448.
302. Mukai, H. Y., Hasegawa, Y., Kojima, H., Okoshi, Y. et al., Nodal CD8 positive cytotoxic T-cell lymphoma: a distinct clinicopathological entity. Mod. Pathol. 2002, 15, 1131-1139.
303. Arnulf, B., Copie-Bergman, C., Delfau-Larue, M. H., Lavergne-Slove, A. et al., Nonhepatosplenic gammadelta T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization. Blood 1998, 91, 1723-1731.
304. Katoh, A., Ohshima, K., Kanda, M., Haraoka, S. et al., Gastrointestinal T cell lymphoma: predominant cytotoxic phenotypes, including alpha/beta, gamma/delta T cell and natural killer cells. Leuk. Lymphoma 2000, 39, 97-111.
305. Murata, T., Nakamura, S., Oka, K., Kawakami, K. et al., Granzyme B-positive primary gastric T-cell lymphoma: gastric T-cell lymphoma with the possibility of extrathymic T cell origin. Pathol. Int. 2000, 50, 853-857.
306. Yamashita, Y., Yatabe, Y., Tsuzuki, T., Nakayama, A. et al., Perforin and granzyme expression in cytotoxic T-cell lymphomas. Mod. Pathol. 1998, 11, 313-323.
307. Kanavaros, P., Vlychou, M., Stefanaki, K., Rontogianni, D. et al., Cytotoxic protein expression in non-Hodgkin"s lymphomas and Hodgkin"s disease. Anticancer Res. 1999, 19, 1209-1216.
308. Ruco, L. P., Di Napoli, A., Pilozzi, E., Talerico, C. et al., Peripheral T cell lymphoma with cytotoxic phenotype: an emerging disease in HIV-infected patients? AIDS Res. Hum. Retroviruses 2004, 20, 129-133.
309. Gopcsa, L., Banyai, A., Jakab, K., Kormos, L. et al., Extensive flow cytometric characterization of plasmacytoid dendritic cell leukemia cells. Eur. J. Haematol. 2005, 75, 346-351.
310. Gaal, K., Sun, N. C., Hernandez, A. M., Arber, D. A., Sinonasal NK/T-cell lymphomas in the United States. Am. J. Surg. Pathol. 2000, 24, 1511-1517.
311. Dargent, J. L., Roufosse, C., Delville, J. P., Kentos, A. et al., Subcutaneous panniculitis-like T-cell lymphoma: further evidence for a distinct neoplasm originating from large granular lymphocytes of T/NK phenotype. J. Cutan. Pathol. 1998, 25, 394-400.
312. Abe, Y., Muta, K., Ohshima, K., Yasumoto, S. et al., Subcutaneous panniculitis by Epstein-Barr virus-infected natural killer (NK) cell proliferation terminating in aggressive subcutaneous NK cell lymphoma. Am. J. Hematol. 2000, 64, 221-225.
313. Yamazaki, K., An ultrastructural study of cutaneous panniculitis-like T-cell lymphoma: cytoplasmic granules and active cellular and cell-to-matrix interaction mimic cytotoxic T-cells. Ultrastruct. Pathol. 2002, 26, 185-190.
314. Papenfuss, J. S., Aoun, P., Bierman, P. J., Armitage, J. O., Subcutaneous panniculitis-like T-cell lymphoma: presentation of 2 cases and observations. Clin. Lymphoma 2002, 3, 175-180.
315. Hoque, S. R., Child, F. J., Whittaker, S. J., Ferreira, S. et al., Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathological, immunophenotypic and molecular analysis of six patients. Br. J. Dermatol. 2003, 148, 516-525.
316. Morice, W. G., Kurtin, P. J., Tefferi, A., Hanson, C. A., Distinct bone marrow findings in T-cell granular lymphocytic leukemia revealed by paraffin section immunoperoxidase stains for CD8, TIA-1, and granzyme B. Blood 2002, 99, 268-274.
317. de Bruin, P. C., Kummer, J. A., van der Valk, P., van Heerde, P. et al., Granzyme B-expressing peripheral T-cell lymphomas: neoplastic equivalents of activated cytotoxic T cells with preference for mucosa-associated lymphoid tissue localization. Blood 1994, 84, 3785-3791.
318. de Bruin, P. C., Jiwa, N. M., Oudejans, J. J., Radaszkiewicz, T., Meijer, C. J., Epstein-Barr virus in primary gastrointestinal T cell lymphomas. Association with gluten-sensitive enteropathy, pathological features, and immunophenotype. Am. J. Pathol. 1995, 146, 861-867.
319. Charton-Bain, M. C., Brousset, P., Bouabdallah, R., Gaulard, P. et al., Variation in the histological pattern of nodal involvement by gamma/delta T-cell lymphoma. Histopathology 2000, 36, 233-239.
320. Kato, M., Ichimura, K., Hayami, Y., Iida, S. et al., Pregnancy-associated cytotoxic lymphoma: a report of 4 cases. Int. J. Hematol. 2001, 74, 186-192.
321. Coyne, J. D., Banerjee, S. S., Bromley, M., Mills, S. et al., Post-transplant T-cell lymphoproliferative disorder/T-cell lymphoma: a report of three cases of T-anaplastic large-cell lymphoma with cutaneous presentation and a review of the literature. Histopathology 2004, 44, 387-393.
322. Felgar, R. E., Steward, K. R., Cousar, J. B., Macon, W. R., T-cell-rich large-B-cell lymphomas contain non-activated CD8+ cytolytic T cells, show increased tumor cell apoptosis, and have lower Bcl-2 expression than diffuse large-B-cell lymphomas. Am. J. Pathol. 1998, 153, 1707-1715.
323. Axdorph, U., Porwit-Macdonald, A., Sjøberg, J., Grimfors, G., Bjørkholm, M., T-cell-rich B-cell lymphoma - diagnostic and therapeutic aspects. APMIS 2002, 110, 379-390.
324. Totonchi, K. F., Engel, G., Weisenberg, E., Rhone, D. P., Macon, W. R., Testicular natural killer/t-cell lymphoma, nasal type, of true natural killer-cell origin. Arch. Pathol. Lab. Med. 2002, 126, 1527-1529.
325. Prado-Garcia, H., Aguilar-Cazares, D., Flores-Vergara, H., Mandoki, J. J., Lopez-Gonzalez, J. S., Effector, memory and naïve CD8+ T cells in peripheral blood and pleural effusion from lung adenocarcinoma patients. Lung Cancer 2005, 47, 361-371.
326. Papewalis, C., Fassnacht, M., Willenberg, H. S., Domberg, J. et al., Dendritic cells as potential adjuvant for immunotherapy in adrenocortical carcinoma. Clin. Endocrinol. (Oxf) 2006, 65, 215-222.
327. Grabenbauer, G. G., Lahmer, G., Distel, L., Niedobitek, G., Tumor-infiltrating cytotoxic T cells but not regulatory T cells predict outcome in anal squamous cell carcinoma. Clin. Cancer Res. 2006, 12, 3355-3360.
328. Verhaegh, M. E., Wever, P. C., Neumann, H. A., Hoekzema, R., Immunohistochemical localization of granzyme B in peritumoral infiltrates of basal cell carcinoma. Br. J. Dermatol. 1997, 137, 1012-1014.
329. Vidal, D., Matías-Guiu, X., Alomar, A., Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma. Clin. Exp. Dermatol. 2004, 29, 518-525.
330. Kontani, K., Sawai, S., Hanaoka, J., Tezuka, N. et al., Involvement of granzyme B and perforin in suppressing nodal metastasis of cancer cells in breast and lung cancers. Eur. J. Surg. Oncol. 2001, 27, 180-186.
331. Dias, S., Thomas, H., Balkwill, F., Multiple molecular and cellular changes associated with tumour stasis and regression during IL-12 therapy of a murine breast cancer model. Int. J. Cancer 1998, 75, 151-157.
332. Hu, S. X., Wang, S., Wang, J. P., Mills, G. B. et al., Expression of endogenous granzyme B in a subset of human primary breast carcinomas. Br. J. Cancer 2003, 89, 135-139.
333. Gückel, B., Rentzsch, C., Nastke, M.-D., Marmé, A. et al., Pre-existing T-cell immunity against mucin-1 in breast cancer patients and healthy volunteers. J. Cancer Res. Clin. Oncol. 2006, 132, 265-274.
334. Cromme, F. V., Walboomers, J. M. M., Van Oostveen, J. W., Stukart, M. J. et al., Lack of granzyme expression in T lymphocytes indicates poor cytotoxic T lymphocyte activation in human papillomavirus-associated cervical carcinomas. Int. J. Gynecol. Cancer 1995, 5, 366-373.
335. Bontkes, H. J., De Gruijl, T. D., Walboomers, J. M., van den Muysenberg, A. J. et al., Assessment of cytotoxic T-lymphocyte phenotype using the specific markers granzyme B and TIA-1 in cervical neoplastic lesions. Br. J. Cancer 1997, 76, 1353-1360.
336. Tiemann, M., Teymoortash, A., Schrader, C., Werner, J. A. et al., Chronic sclerosing sialadenitis of the submandibular gland is mainly due to a T lymphocyte immune reaction. Mod. Pathol. 2002, 15, 845-852.
337. Go, J. H., Pure choriocarcinoma of testis with tumor-infiltrating lymphocytes and granulomas. Yonsei Med. J. 2006, 47, 887-891.
338. Michael-Robinson, J. M., Pandeya, N., Walsh, M. D., Biemer-Huttmann, A.-E. et al., Characterization of tumour-infiltrating lymphocytes and apoptosis in colitis-associated neoplasia: comparison with sporadic colorectal cancer. J. Pathol. 2006, 208, 381-387.
339. Mizoguchi, H., O'Shea, J. J., Longo, D. L., Loeffler, C. M. et al., Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science 1992, 258, 1795-1798.
340. Mulder, W. M., Bloemena, E., Stukart, M. J., Kummer, J. A. et al., T cell receptor-zeta and granzyme B expression in mononuclear cell infiltrates in normal colon mucosa and colon carcinoma. Gut 1997, 40, 113-119.
341. Sandel, M. H., Speetjens, F. M., Menon, A. G., Albertsson, P. A. et al., Natural killer cells infiltrating colorectal cancer and MHC class I expression. Mol. Immunol. 2005, 42, 541-546.
342. Pagès, F., Berger, A., Camus, M., Sanchez-Cabo, F. et al., Effector memory T cells, early metastasis, and survival in colorectal cancer. N. Engl. J. Med. 2005, 353, 2654-2666.
343. Peng, Y.-P., Zhu, Y., Zhang, J.-J., Xu, Z.-K. et al., Comprehensive analysis of the percentage of surface receptors and cytotoxic granules positive natural killer cells in patients with pancreatic cancer, gastric cancer, and colorectal cancer. J. Transl. Med. 2013, 11, 262.
344. Naito, Y., Saito, K., Shiiba, K., Ohuchi, A. et al., CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res. 1998, 58, 3491-3494.
345. Phillips, S. M., Banerjea, A., Feakins, R., Li, S. R. et al., Tumour-infiltrating lymphocytes in colorectal cancer with microsatellite instability are activated and cytotoxic. Br. J. Surg. 2004, 91, 469-475.
346. Kondratiev, S., Sabo, E., Yakirevich, E., Lavie, O., Resnick, M. B., Intratumoral CD8+ T lymphocytes as a prognostic factor of survival in endometrial carcinoma. Clin. Cancer Res. 2004, 10, 4450-4456.
347. Risinger, J. I., Chandramouli, G. V. R., Maxwell, G. L., Litzi, T. et al., Gene expression analysis of tumor infiltrating lymphocyte markers in endometrial cancers indicates no significant increases in those cases with microsatellite instability. Cancer Biomark. 2006, 2, 61-68.
348. Mahjoub, W. K., Chretien, F., Gherardi, R., Ortonne, N., Intracellular spread of Ewing's sarcoma within skeletal muscle fibres: is there a role for cytotoxic tumour-infiltrating lymphocytes? Histopathology 2006, 48, 623-626.
349. van Beek, J., Hausen zur, A., Snel, S. N., Berkhof, J. et al., Morphological evidence of an activated cytotoxic T-cell infiltrate in EBV-positive gastric carcinoma preventing lymph node metastases. Am. J. Surg. Pathol. 2006, 30, 59-65.
350. Tsukishiro, T., Donnenberg, A. D., Whiteside, T. L., Rapid turnover of the CD8(+)CD28(-) T-cell subset of effector cells in the circulation of patients with head and neck cancer. Cancer Immunol. Immunother. 2003, 52, 599-607.
351. Lugade, A. A., Kalathil, S., Miller, A., Iyer, R., Thanavala, Y., High immunosuppressive burden in advanced hepatocellular carcinoma patients: can effector functions be restored? Oncoimmunology 2013, 2, e24679.
352. Hayashida, M., Kawano, H., Nakano, T., Shiraki, K., Suzuki, A., Cell death induction by CTL: perforin/granzyme B system dominantly acts for cell death induction in human hepatocellular carcinoma cells. Proc. Soc. Exp. Biol. Med. 2000, 225, 143-150.
353. Shang, X.-Y., Chen, H.-S., Zhang, H.-G., Pang, X.-W. et al., The spontaneous CD8+ T-cell response to HLA-A2-restricted NY-ESO-1b peptide in hepatocellular carcinoma patients. Clin. Cancer Res. 2004, 10, 6946-6955.
354. Unitt, E., Rushbrook, S. M., Marshall, A., Davies, S. et al., Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells. Hepatology 2005, 41, 722-730.
355. Cicinnati, V. R., Zhang, X., Yu, Z., Ferencik, S. et al., Increased frequencies of CD8+ T lymphocytes recognizing wild-type p53-derived epitopes in peripheral blood correlate with presence of epitope loss tumor variants in patients with hepatocellular carcinoma. Int. J. Cancer 2006, 119, 2851-2860.
356. Batinac, T., Zamolo, G., Coklo, M., Hadzisejdic, I., Possible key role of granzyme B in keratoacanthoma regression. Med. Hypotheses 2006, 66, 1129-1132.
357. Yakirevich, E., Izhak, O. B., Rennert, G., Kovacs, Z. G., Resnick, M. B., Cytotoxic phenotype of tumor infiltrating lymphocytes in medullary carcinoma of the breast. Mod. Pathol. 1999, 12, 1050-1056.
358. Oudejans, J. J., Harijadi, H., Kummer, J. A., Tan, I. B. et al., High numbers of granzyme B/CD8-positive tumour-infiltrating lymphocytes in nasopharyngeal carcinoma biopsies predict rapid fatal outcome in patients treated with curative intent. J. Pathol. 2002, 198, 468-475.
359. Verdegaal, E. M. E., Hoogstraten, C., Sandel, M. H., Kuppen, P. J. K. et al., Functional CD8+ T cells infiltrate into nonsmall cell lung carcinoma. Cancer Immunol. Immunother. 2007, 56, 587-600.
360. Cruz, I., Meijer, C. J., Walboomers, J. M., Snijders, P. J., Van der Waal, I., Lack of MHC class I surface expression on neoplastic cells and poor activation of the secretory pathway of cytotoxic cells in oral squamous cell carcinomas. Br. J. Cancer 1999, 81, 881-889.
361. Nijman, H. W., van Diest, P. J., Poort-Keesom, R. J., Mensdorff-Pouilly von, S. et al., T cell infiltration and MHC I and II expression in the presence of tumor antigens: an immunohistochemical study in patients with serous epithelial ovarian cancer. Eur. J. Obstet. Gynecol. Reprod. Biol. 2001, 94, 114-120.
362. Kudoh, S., Redovan, C., Rayman, P., Edinger, M. et al., Defective granzyme B gene expression and lytic response in T lymphocytes infiltrating human renal cell carcinoma. J. Immunother. 1997, 20, 479-487.
363. Schleypen, J. S., Baur, N., Kammerer, R., Nelson, P. J. et al., Cytotoxic markers and frequency predict functional capacity of natural killer cells infiltrating renal cell carcinoma. Clin. Cancer Res. 2006, 12, 718-725.
364. Haider, A. S., Peters, S. B., Kaporis, H., Cardinale, I. et al., Genomic analysis defines a cancer-specific gene expression signature for human squamous cell carcinoma and distinguishes malignant hyperproliferation from benign hyperplasia. J. Invest. Dermatol. 2006, 126, 869-881.
365. Yakirevich, E., Lefel, O., Sova, Y., Stein, A. et al., Activated status of tumour-infiltrating lymphocytes and apoptosis in testicular seminoma. J. Pathol. 2002, 196, 67-75.
366. Hadrup, S. R., Braendstrup, O., Jacobsen, G. K., Mortensen, S. et al., Tumor infiltrating lymphocytes in seminoma lesions comprise clonally expanded cytotoxic T cells. Int. J. Cancer 2006, 119, 831-838.
367. Kook, H., Zeng, W., Guibin, C., Kirby, M. et al., Increased cytotoxic T cells with effector phenotype in aplastic anemia and myelodysplasia. Exp. Hematol. 2001, 29, 1270-1277.
368. Xu, J. L., Nagasaka, T., Nakashima, N., Involvement of cytotoxic granules in the apoptosis of aplastic anaemia. Br. J. Haematol. 2003, 120, 850-852.
369. Zhang, F., Chu, X., Wang, L., Zhu, Y. et al., Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura. Eur. J. Haematol. 2006, 76, 427-431.
370. Olsson, B., Andersson, P.-O., Jernås, M., Jacobsson, S. et al., T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat. Med. 2003, 9, 1123-1124.
371. Olsson, B., Jernås, M., Wadenvik, H., Increased plasma levels of granzymes in adult patients with chronic immune thrombocytopenia. Thromb. Haemost. 2012, 107, 1-3.
372. Choy, J. C., Cruz, R. P., Kerjner, A., Geisbrecht, J. et al., Granzyme B induces endothelial cell apoptosis and contributes to the development of transplant vascular disease. Am. J. Transplant. 2005, 5, 494-499.
373. Choy, J. C., Kerjner, A., Wong, B. W., McManus, B. M., Granville, D. J., Perforin mediates endothelial cell death and resultant transplant vascular disease in cardiac allografts. Am. J. Pathol. 2004, 165, 127-133.
374. Ocaña, E., Pérez-Requena, J., Bohórquez, J.-C., Brieva, J. A., Rodríguez, C., Chemokine receptor expression on infiltrating lymphocytes from abdominal aortic aneurysms: role of CXCR4-CXCL12 in lymphoid recruitment. Atherosclerosis 2008, 200, 264-270.
375. Kuijpers, T. W., Biezeveld, M., Achterhuis, A., Kuipers, I. et al., Longstanding obliterative panarteritis in Kawasaki disease: lack of cyclosporin A effect. Pediatrics 2003, 112, 986-992.
376. Guzman-Cottrill, J. A., Garcia, F. L., Shulman, S. T., Rowley, A. H., CD8 T lymphocytes do not express cytotoxic proteins in coronary artery aneurysms in acute Kawasaki disease. Pediatr. Infect. Dis. J. 2005, 24, 382-384.
377. Choy, J. C., McDonald, P. C., Suarez, A. C., Hung, V. H. Y. et al., Granzyme B in atherosclerosis and transplant vascular disease: association with cell death and atherosclerotic disease severity. Mod. Pathol. 2003, 16, 460-470.
378. Altimari, A., Gruppioni, E., Capizzi, E., Bagni, A. et al., Blood monitoring of granzyme B and perforin expression after intestinal transplantation: considerations on clinical relevance. Transplantation 2008, 85, 1778-1783.
379. Kummer, J. A., Wever, P. C., Kamp, A. M., Berge ten, I. J. et al., Expression of granzyme A and B proteins by cytotoxic lymphocytes involved in acute renal allograft rejection. Kidney Int. 1995, 47, 70-77.
380. van Ham, S. M., Heutinck, K. M., Jorritsma, T., Bemelman, F. J. et al., Urinary granzyme A mRNA is a biomarker to diagnose subclinical and acute cellular rejection in kidney transplant recipients. Kidney Int. 2010, 78, 1033-1040.
381. Brown, T. J., Crawford, S. E., Cornwall, M. L., Garcia, F. et al., CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease. J. Infect. Dis. 2001, 184, 940-943.
382. Vernooy, J. H. J., Möller, G. M., van Suylen, R. J., van Spijk, M. P. et al., Increased granzyme A expression in type II pneumocytes of patients with severe chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2007, 175, 464-472.
383. Bem, R. A., van Woensel, J. B. M., Lutter, R., Domachowske, J. B. et al., Granzyme A- and B-cluster deficiency delays acute lung injury in pneumovirus-infected mice. J. Immunol. 2010, 184, 931-938.
384. Hirota, J. A., Hiebert, P. R., Gold, M., Wu, D. et al., Granzyme B deficiency exacerbates lung inflammation in mice following acute lung injury. Am. J. Respir. Cell. Mol. Biol. 2013, 49, 453-642.
385. Tschopp, C. M., Spiegl, N., Didichenko, S., Lutmann, W. et al., Granzyme B, a novel mediator of allergic inflammation: its induction and release in blood basophils and human asthma. Blood 2006, 108, 2290-2299.
386. Bratke, K., Kuepper, M., Bade, B., Virchow, J. C., Luttmann, W., Differential expression of human granzymes A, B, and K in natural killer cells and during CD8+ T cell differentiation in peripheral blood. Eur. J. Immunol. 2005, 35, 2608-2616.
387. Hodge, S., Hodge, G., Nairn, J., Holmes, M., Reynolds, P. N., Increased airway granzyme b and perforin in current and ex-smoking COPD subjects. COPD 2006, 3, 179-187.
388. Kim, W.-D., Chi, H.-S., Choe, K.-H., Oh, Y.-M. et al., A possible role for CD8 +and non-CD8+ cell granzyme B in early small airway wall remodelling in centrilobular emphysema. Respirology 2013, 18, 688-696.
389. Urbanowicz, R. A., Lamb, J. R., Todd, I., Corne, J. M., Fairclough, L. C., Altered effector function of peripheral cytotoxic cells in COPD. Respir. Res. 2009, 10, 53.
390. Dourado, M., Bento, J., Mesquita, L., Marques, A. et al., Granzymes A and B in pulmonary sarcoidosis (experimental study). Rev. Port. Pneumol. 2005, 11, 111-133.
391. Trivedi, N. R., Gilliland, K. L., Zhao, W., Liu, W., Thiboutot, D. M., Gene array expression profiling in acne lesions reveals marked upregulation of genes involved in inflammation and matrix remodeling. J. Invest. Dermatol. 2006, 126, 1071-1079.
392. Yawalkar, N., Hunger, R. E., Buri, C., Schmid, S. et al., A comparative study of the expression of cytotoxic proteins in allergic contact dermatitis and psoriasis: spongiotic skin lesions in allergic contact dermatitis are highly infiltrated by T cells expressing perforin and granzyme B. Am. J. Pathol. 2001, 158, 803-808.
393. Bodemer, C., Peuchmaur, M., Fraitaig, S., Chatenoud, L. et al., Role of cytotoxic T cells in chronic alopecia areata. J. Invest. Dermatol. 2000, 114, 112-116.
394. Sato-Kawamura, M., Aiba, S., Tagami, H., Strong expression of CD40, CD54 and HLA-DR antigen and lack of evidence for direct cellular cytotoxicity are unique immunohistopathological features in alopecia areata. Arch. Dermatol. Res. 2003, 294, 536-543.
395. Siebenhaar, F., Sharov, A. A., Peters, E. M. J., Sharova, T. Y. et al., Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata). J. Invest. Dermatol. 2007, 127, 1489-1497.
396. Hussein, M. R., Ali, F. M. N., Omar, A.-E. M. M., Immunohistological analysis of immune cells in blistering skin lesions. J. Clin. Pathol. 2007, 60, 62-71.
397. Abdou, A. G., Shoeib, M., Bakry, O. A., El-Bality, H., Immunohistochemical expression of granzyme B and perforin in discoid lupus erythematosus. Ultrastruct. Pathol. 2013, 37, 408-416.
398. Iwatsuki, K., Satoh, M., Yamamoto, T., Oono, T. et al., Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders. Arch. Dermatol. 2006, 142, 587-595.
399. Hunger, R. E., Brönnimann, M., Kappeler, A., Mueller, C. et al., Detection of perforin and granzyme B mRNA expressing cells in lichen sclerosus. Exp. Dermatol. 2007, 16, 416-420.
400. Gross, T., Wagner, A., Ugurel, S., Tilgen, W., Reinhold, U., Identification of TIA-1+ and granzyme B+ cytotoxic T cells in lichen sclerosus et atrophicus. Dermatology (Basel) 2001, 202, 198-202.
401. Lage, D., Juliano, P. B., Metze, K., de Souza, E. M., Cintra, M. L., Lichen planus and lichenoid drug-induced eruption: a histological and immunohistochemical study. Int. J. Dermatol. 2012, 51, 1199-1205.
402. Takahashi, H., Amagai, M., Tanikawa, A., Suzuki, S. et al., T helper type 2-biased natural killer cell phenotype in patients with pemphigus vulgaris. J. Invest. Dermatol. 2007, 127, 324-330.
403. Hernandez-Pigeon, H., Jean, C., Charruyer, A., Haure, M.-J. et al., Human keratinocytes acquire cellular cytotoxicity under UV-B irradiation. Implication of granzyme B and perforin. J. Biol. Chem. 2006, 281, 13525-13532.
404. Hernandez-Pigeon, H., Jean, C., Charruyer, A., Haure, M.-J. et al., UVA induces granzyme B in human keratinocytes through MIF: implication in extracellular matrix remodeling. J. Biochem. 2007, 282, 8157-8164.
405. Hussein, M. R. A., Abdel-Magid, W. M., Saleh, R., Nada, E., Phenotypical characteristics of the immune cells in allergic contact dermatitis, atopic dermatitis and pityriasis rosea. Pathol. Oncol. Res. 2009, 15, 73-79.
406. Weenig, R. H., Daniel Su, W. P., Subcutaneous panniculitis-like T-cell lymphoma presenting as venous stasis ulceration. Int. J. Dermatol. 2006, 45, 1083-1085.
407. Borchers, A. T., Lee, J. L., Naguwa, S. M., Cheema, G. S., Gershwin, M. E., Stevens-Johnson syndrome and toxic epidermal necrolysis. Autoimmun. Rev. 2008, 7, 598-605.
408. Chave, T. A., Mortimer, N. J., Sladden, M. J., Hall, A. P., Hutchinson, P. E., Toxic epidermal necrolysis: current evidence, practical management and future directions. Br. J. Dermatol. 2005, 153, 241-253.
409. Ferrara, T. M., Jin, Y., Gowan, K., Fain, P. R., Spritz, R. A., Risk of generalized vitiligo is associated with the common 55R-94A-247H variant haplotype of GZMB (encoding granzyme B). J. Invest. Dermatol. 2013, 133, 1677-1679.
410. Oyarbide-Valencia, K., van den Boorn, J. G., Denman, C. J., Li, M. et al., Therapeutic implications of autoimmune vitiligo T cells. Autoimmun. Rev. 2006, 5, 486-492.
411. Nordström, D. C., Konttinen, Y. T., Sorsa, T., Nykanen, P. et al., Granzyme A-immunoreactive cells in synovial fluid in reactive and rheumatoid arthritis. Clin. Rheumatol. 1992, 11, 529-532.
412. Smeets, T. J., Dolhain, R. J., Breedveld, F. C., Tak, P. P., Analysis of the cellular infiltrates and expression of cytokines in synovial tissue from patients with rheumatoid arthritis and reactive arthritis. J. Pathol. 1998, 186, 75-81.
413. Tak, P. P., Spaeny-Dekking, L., Kraan, M. C., Breedveld, F. C. et al., The levels of soluble granzyme A and B are elevated in plasma and synovial fluid of patients with rheumatoid arthritis (RA). Clin. Exp. Immunol. 1999, 116, 366-370.
414. Thewissen, M., Somers, V., Venken, K., Linsen, L. et al., Analyses of immunosenescent markers in patients with autoimmune disease. Clin. Immunol. 2007, 123, 209-218.
415. Shivakumar, P., Mourya, R., Bezerra, J. A., Perforin and granzymes work in synergy to mediate cholangiocyte injury in experimental biliary atresia. J. Hepatol. 2014, 60, 370-376.
416. Mitomi, H., Ohkura, Y., Yokoyama, K., Sada, M. et al., Contribution of TIA-1+ and granzyme B +cytotoxic T lymphocytes to cryptal apoptosis and ulceration in active inflammatory bowel disease. Pathol. Res. Pract. 2007, 203, 717-723.
417. Jenkins, D., Seth, R., Kummer, J. A., Scott, B. B. et al., Differential levels of granzyme B, regulatory cytokines, and apoptosis in Crohn's disease and ulcerative colitis at first presentation. J. Pathol. 2000, 190, 184-189.
418. León, A. J., Gómez, E., Garrote, J. A., Bernardo, D. et al., High levels of proinflammatory cytokines, but not markers of tissue injury, in unaffected intestinal areas from patients with IBD. Mediators Inflamm. 2009, 2009, 580450.
419. Hirayasu, H., Yoshikawa, Y., Tsuzuki, S., Fushiki, T., A role of a lymphocyte tryptase, granzyme A, in experimental ulcerative colitis. Biosci. Biotechnol. Biochem. 2007, 71, 234-237.
420. Yadav, A. K., Lal, A., Jha, V., Cytotoxic CD4CD28(null) T lymphocytes, systemic inflammation and atherosclerotic risk in patients with chronic kidney disease. Nephron. Clin. Pract. 2012, 120, c185-c193.
421. Reynolds, J., Norgan, V. A., Bhambra, U., Smith, J. et al., Anti-CD8 monoclonal antibody therapy is effective in the prevention and treatment of experimental autoimmune glomerulonephritis. J. Am. Soc. Nephrol. 2002, 13, 359-369.
422. Fujinaka, H., Yamamoto, T., Feng, L., Nameta, M. et al., Anti-perforin antibody treatment ameliorates experimental crescentic glomerulonephritis in WKY rats. Kidney Int. 2007, 72, 823-830.
423. Meade, J. L., de Wynter, E. A., Brett, P., Sharif, S. M. et al., A family with Papillon-Lefevre syndrome reveals a requirement for cathepsin C in granzyme B activation and NK cell cytolytic activity. Blood 2006, 107, 3665-3668.
424. Pham, C. T. N., Ivanovich, J. L., Raptis, S. Z., Zehnbauer, B., Ley, T. J., Papillon-Lefèvre syndrome: correlating the molecular, cellular, and clinical consequences of cathepsin C/dipeptidyl peptidase I deficiency in humans. J. Immunol. 2004, 173, 7277-7281.
425. Teymoortash, A., Tiemann, M., Schrader, C., Werner, J. A., Characterization of lymphoid infiltrates in chronic obstructive sialadenitis associated with sialolithiasis. J. Oral Pathol. Med. 2004, 33, 300-304.
426. Teymoortash, A., Simolka, N., Schrader, C., Tiemann, M., Werner, J. A., Lymphocyte subsets in irradiation-induced sialadenitis of the submandibular gland. Histopathology 2005, 47, 493-500.
427. Clark, S. B., Rice, T. W., Tubbs, R. R., Richter, J. E., Goldblum, J. R., The nature of the myenteric infiltrate in achalasia: an immunohistochemical analysis. Am. J. Surg. Pathol. 2000, 24, 1153-1158.
428. Rubio, C. A., Sjödahl, K., Lagergren, J., Lymphocytic esophagitis: a histologic subset of chronic esophagitis. Am. J. Clin. Pathol. 2006, 125, 432-437.
429. Resnick, M. B., Finkelstein, Y., Weissler, A., Levy, J., Yakirevich, E., Assessment and diagnostic utility of the cytotoxic T-lymphocyte phenotype using the specific markers granzyme-B and TIA-1 in esophageal mucosal biopsies. Hum. Pathol. 1999, 30, 397-402.
430. Wanschitz, J., Maier, H., Lassmann, H., Budka, H., Berger, T., Distinct time pattern of complement activation and cytotoxic T cell response in Guillain-Barré syndrome. Brain 2003, 126, 2034-2042.
431. Tian, Y., Stamova, B., Jickling, G. C., Liu, D. et al., Effects of gender on gene expression in the blood of ischemic stroke patients. J. Cereb. Blood Flow Metab. 2012, 32, 780-791.
432. Chaitanya, G. V., Eeka, P., Munker, R., Alexander, J. S., Babu, P. P., Role of cytotoxic protease granzyme-b in neuronal degeneration during human stroke. Brain Pathol. 2011, 21, 16-30.
433. Malmeström, C., Lycke, J., Haghighi, S., Andersen, O. et al., Relapses in multiple sclerosis are associated with increased CD8+ T-cell mediated cytotoxicity in CSF. J. Neuroimmunol. 2008, 196, 159-165.
434. Pouly, S., Antel, J. P., Multiple sclerosis and central nervous system demyelination. J. Autoimmun. 1999, 13, 297-306.
435. Gahring, L., Carlson, N. G., Meyer, E. L., Rogers, S. W., Granzyme B proteolysis of a neuronal glutamate receptor generates an autoantigen and is modulated by glycosylation. J. Immunol. 2001, 166, 1433-1438.
436. Bauer, J., Bien, C. G., Lassmann, H., Rasmussen's encephalitis: a role for autoimmune cytotoxic T lymphocytes. Curr. Opin. Neurol. 2002, 15, 197-200.
437. Bien, C. G., Bauer, J., Deckwerth, T. L., Wiendl, H. et al., Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis. Ann. Neurol. 2002, 51, 311-318.
438. Bauer, J., Elger, C. E., Hans, V. H., Schramm, J. et al., Astrocytes are a specific immunological target in Rasmussen's encephalitis. Ann. Neurol. 2007, 62, 67-80.
439. Oka, N., Takahashi, M., Kawasaki, T., Akiguchi, I., Apoptosis of perineurial cells in sensory perineuritis. Acta Neuropathol. 2000, 99, 317-320.
440. Chaitanya, G. V., Kolli, M., Babu, P. P., Granzyme-b mediated cell death in the spinal cord-injured rat model. Neuropathology 2009, 29, 270-279.
441. Ilzecka, J., Granzymes A and B levels in serum of patients with amyotrophic lateral sclerosis. Clin. Biochem. 2011, 44, 650-653.
442. Baetz, K., Isaaz, S., Griffiths, G. M., Loss of cytotoxic T lymphocyte function in Chediak-Higashi syndrome arises from a secretory defect that prevents lytic granule exocytosis. J. Immunol. 1995, 154, 6122-6131.
443. Yakirevich, E., Yanai, O., Sova, Y., Sabo, E. et al., Cytotoxic phenotype of intra-epithelial lymphocytes in normal and cryptorchid human testicular excurrent ducts. Hum. Reprod. 2002, 17, 275-283.
444. Arahata, K., Ishihara, T., Fukunaga, H., Orimo, S. et al., Inflammatory response in facioscapulohumeral muscular dystrophy (FSHD): immunocytochemical and genetic analyses. Muscle Nerve Suppl. 1995, 18, S56-S66.